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 Abstract 
Enterococci are the third leading cause of nosocomial infections including urinary 
tract infections (UTI), surgical site infections (SSI) and blood stream infections.  
Enterococci are also found in the gastrointestinal tracts of humans, and other mammals.  
We elucidated the influence of the transcriptional regulator RpoN on enterococcal 
biofilm formation, virulence potential and cell wall architecture and proposed a potential 
involvement for carbohydrate metabolism in these processes. Biofilms are held together 
by matrix (BM) components such as extracellular DNA (eDNA) released by cell death 
from a sub-population of cells. The rpoN mutant (ΔrpoN) was resistant to autolysis as 
well as fratricide-mediated cell death and eDNA was not detected in planktonic as well as 
biofilm cultures.  Unlike the parental strain V583, the ΔrpoN mutant formed proteinase K 
sensitive biofilms, suggesting that protein as well as eDNA serves as an important matrix 
component. The rabbit model of endocarditis was used to assess the effect of rpoN 
deletion on enterococcal virulence. Rabbits infected with ΔrpoN had reduced bacterial 
burden in heart, blood, liver, kidney and vegetation in comparison to the parental strain. 
The growth defect of ΔrpoN in physiologically relevant glucose levels  partially explains 
the reduced bacterial burdens observed in the virulence study. Microarray analysis of 
ΔrpoN showed that 10% of the genome is differentially regulated by RpoN. Deletion of 
rpoN also protects Enterococcus faecalis from lysis in the absence of known modulators 
of cellular lytic events such as O-acetylation and D-alanylation. Of the four identified 
enhancer binding proteins in E. faecalis, MptR regulates the RpoN-dependent 
mannose/glucose uptake system (MptABCD) and the ΔmptR mutant phenocopied the 
ΔrpoN mutant in the eDNA release and growth assays.  Because MptC and MptD have 
 been shown to be the cellular receptors for Class IIa and IIc bacteriocins, we are presently 
testing the hypothesis that these receptors may serve as a global receptor for bacteriocins.  
In conclusion, our data demonstrates that alterations in the metabolic state of the 
bacterium, as observed in the ΔrpoN mutant could be responsible for the switch in 
biofilm matrix composition, and this switch in turn likely influences the virulence 
potential of the bacterium. 
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 Abstract 
Enterococci are the third leading cause of nosocomial infections including urinary 
tract infections (UTI), surgical site infections (SSI) and blood stream infections.  
Enterococci are also found in the gastrointestinal tracts of humans, and other mammals.  
We elucidated the influence of the transcriptional regulator RpoN on enterococcal 
biofilm formation, virulence potential and cell wall architecture and proposed a potential 
involvement for carbohydrate metabolism in these processes. Biofilms are held together 
by matrix (BM) components such as extracellular DNA (eDNA) released by cell death 
from a sub-population of cells. The rpoN mutant (ΔrpoN) was resistant to autolysis as 
well as fratricide-mediated cell death and eDNA was not detected in planktonic as well as 
biofilm cultures.  Unlike the parental strain V583, the ΔrpoN mutant formed proteinase K 
sensitive biofilms, suggesting that protein as well as eDNA serves as an important matrix 
component. The rabbit model of endocarditis was used to assess the effect of rpoN 
deletion on enterococcal virulence. Rabbits infected with ΔrpoN had reduced bacterial 
burden in heart, blood, liver, kidney and vegetation in comparison to the parental strain. 
The growth defect of ΔrpoN in physiologically relevant glucose levels (5 mM) partially 
explains the reduced bacterial burdens observed in the virulence study. Microarray 
analysis of ΔrpoN showed that 10% of the genome is differentially regulated by RpoN. 
Deletion of rpoN also protects Enterococcus faecalis from lysis in the absence of known 
modulators of cellular lytic events such as O-acetylation and D-alanylation. Of the four 
identified enhancer binding proteins in E. faecalis, MptR regulates the RpoN-dependent 
mannose/glucose uptake system (MptABCD) and the ΔmptR mutant phenocopied the 
ΔrpoN mutant in the eDNA release and growth assays.  Because MptC and MptD have 
 been shown to be the cellular receptors for class IIa and IIc bacteriocins, we are presently 
testing the hypothesis that these receptors may serve as a global receptor for bacteriocins.  
In conclusion, our data demonstrates that alterations in the metabolic state of the 
bacterium, as observed in the ΔrpoN mutant could be responsible for the switch in 
biofilm matrix composition, and this switch in turn likely influences the virulence 
potential of the bacterium. 
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1.1 Enterococci  
In 1899, Thiercelin identified enterococci as a Gram positive intestinal 
commensal capable of forming long chains. It was initially classified as Streptococcus 
but in 1984, it was recognized as the separate genus of Enterococcuson the basis of its 
distinct genetic differences from the streptococci (99). The progressive transition of 
enterococci from a benevolent intestinal commensal to a pathogen is due to the extended 
use of broad-spectrum antibiotics and horizontal gene transfer (81). As opportunistic 
pathogens, enterococci, rank third after coagulase negative staphylococci and 
Staphylococcus aureus. Out of the total hospital acquired or associated infections 
reported, enterococci are responsible for 11.2 % surgical site infection (SSI), 14.9% of 
urinary tract infection (UTI) and 16% of the reported blood stream infection (38). Of all 
the known enterococci, two main species Enterococcus faecalis and Enterococcus 
faecium predominantly colonize the intestine and have been causative agents for several 
infections (44). Despite the increasing incidence of E. faecium infections and its slow 
emergence as a nosocomial pathogen (3), most enterococcal infections reported continue 
to be caused by E. faecalis (39). The intrinsic and acquired resistance of  E. faecalis to 
antimicrobial agents makes it important to understand the pathogenesis of this organism. 
The development of vancomycin resistance in E. faecalis strains, severely limited the 
therapeutic options as vancomycin had been the only therapeutic for the penicillin and 
aminoglycoside resistant E. faecalis (34, 43, 62).  The recently acquired resistance to 
newer antibiotics such as linezolid, dalfopristin and daptomycin (12, 37, 49, 68) raises 
clinical concerns about the ongoing effectiveness of  treatments for E. faecalis infections. 
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This alarming increase in multiple antibiotic resistances over a period of years and its 
spread through mutation and horizontal gene transfer (80, 81, 124, 128) has increased the 
need to deepen our understanding about these organisms and find alternative therapies to 
combat such infections. The virulence properties of E. faecalis thus need to be well 
understood in order to combat infections produced by this multiple antibiotic resistant 
organism. Several factors such as cytolysins, aggregation factors, Enterococcussurface 
proteins, biofilm formation and capsule production play an important role in its 
pathogenesis (47, 58, 98). 
1.2 Enterococcal cell wall physiology 
The enterococcal cell wall is composed of several polymers including the capsular 
polysaccharide, the integral cell wall teichoic acid, group D antigen or lipoteichoic acid 
and rhamnopolymer that bears close resemblance the streptococcal group us antigens 
(29).  
Capsular polysaccharide:  
In E. faecalis, the surface exposed carbohydrate (capsule) consists of a repeating 
polymer of glucose and galactofuranose with substitutions of O-acetyl and lactic acid at 
positions 5 and 3 on the Galf residue, respectively (29, 116).  Bacterial surface 
polysaccharides are known to play an important role in virulence by preventing the 
engulfment and digestion of the organism by host macrophages and neutrophils, allowing 
it to evade the immune system (3). Highly encapsulated stains of E. faecalis (9) and 
isolates that are resistant to phagocytosis in the absence of opsonic antibodies (40) have 
been reported. It has also been shown that mutants that lack the ability to produce capsule 
are readily engulfed by macrophages. The capsule in E. faecalis, has been shown to mask 
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other cell surface antigens such as lipoteichoic acid (LTA), which is a known stimulator 
of the human immune response during enterococcal infection (119). 
The first report describing a locus involved in polysaccharide biosynthesis in E. 
faecalis was reported by Xu et al. (1997) in the strain OG1RF (130). However, later 
investigations led to the conclusion that the polysaccharide synthesized by this gene was 
not extracellular and hence was disregarded as a locus responsible for capsule 
polysaccharide biosynthesis (131). In 2002, Hancock et al. reported an operon in E. 
faecalis strain FA2-2, consisting of 11 open reading frame (CpsA to CpsK) under the 
control of two promoters, responsible for capsule polysaccharide production (29). Later it 
was shown that CpsA and CpsB were not involved in capsular polysaccharide synthesis 
however, their presence was important for  cell survival (31). The same group reported 
two regions of diad symmetry to the 5’ end of the cpsC promoter. The deletion of the first 
region caused a two-fold increase in the promoter activity from the cpsC promoter 
indicating a potential regulatory role in capsule polysaccharide synthesis (31).  
The expression of cps genes in E. faecalis has also been reported to be maximum 
in the mid logarithmic phase in comparison to the stationary phase (>10 fold) (31). 
Qualitative estimation of capsule production from E. faecalis strain FA2-2 at different 
stages of growth has also shown a mid-logarithmic increase in capsule production (Iyer 
VS, unpublished data). According to the proposed model for polysaccharide synthesis, in 
the first step, monosaccharide must be first activated by linkage to a nucleotide molecule. 
However, the trigger for this activation is unknown. Recently, Thurlow et al. 
characterized the nine gene operon responsible for sysnthesis of capsular polysaccharide 
in E. faecalis and showed that only seven out of nine genes are required for capsule 
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production (119). Using immunodetection methods,  E. faecalis has been shown to 
produce four distinct cell wall polymers named A, B, C and D (41), however only 
serotypes C and D make a capsular polysaccharide (119).  Out of the seven genes in the 
operon, it was postulated that the gene product of cpsF was responsible for the 
glucosylation of serotype C capsular polysaccharide and determing the serospecificity in 
serotypes C and D as CpsF is found only in E. faecalis serotype C (119).  
Lipoteichoic Acid, Wall Teichoic Acid and Rhamnopolymer: 
Noncovalently inserted into the cell membrane by a glycolipid anchor is the 
lipoteichoic acid (LTA) or the group D antigen which is an amphiphilic polymer made up 
of polyglycerol phosphate. The C-2 of glycerol residue in LTA is modified by the 
addition of D-alanine.  LTA has been associated with several bacterial functions such as 
anchoring of cell wall proteins, membrane elasticity and porosity , determination of 
hydrophobicity and net charge as well as trafficking of molecules (76). Antibodies 
directed to non-encapsulated E. faecalis target the exposed enterococcal LTA and result 
in opsonophagocytosis. Thus LTA in enterococci is also a major antigenic determinant 
(115). LTA is also partially responsible for the inflammatory response elicited by E. 
faecalis because it stimulates the murine macrophages to secret tumor necrosis factor 
alpha (TNF-α) and nitric oxide and activates the Toll like receptor 2 (TLR-2) (4). 
In addition to lipoteichoic acid, enterococci and other Gram positive bacteria 
contain a wall teichoic acid which is covalently attached to the cell wall and is composed 
of D-glucose, D-galactose, 2-acetamido-2-deoxy-D-galactose, 2-acetamido-2-deoxy-D-
glucose, D-ribitol, and phosphate in a molar ratio 1:2:1:1:1:1 (114) . Similar to LTA, the 
wall teichoic acid also contains D-alanylated esters in their structure (76) .  
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Another cell wall associated polymer of E. faecalis is the rhamnopolysaccharide 
also called as Epa which is encoded by a highly conserved epa locus (113, 131). Because 
of the inability to detect the Epa antigen with the antiserum in several strains of E. 
faecalis (131), Hancock et al (2002) proposed that this rhamnopolymer is located in the 
deeper layers of the enterococcal cell wall (29).  The epa mutants are more susceptible to 
phagocytic killing (112) and show gross changes in their cell shape (113) which may 
partly be responsible to the phenotypic effects observed in their virulence studies (131, 
132). 
In many Gram positive bacteria the D-alanylation of teichoic acid plays an 
important role in susceptibility to lysis, adherence, resistance to antimicrobial peptides 
and virulence. D-alanine incorporation is catalyzed by the gene products of the four gene 
dlt operon (dltA-D) (1, 50, 53, 82-84, 90). Similarly, in E. faecalis the D-alanylation 
partly contributes to lysis resistance (57) and a dltA mutant is defective in biofilm 
formation, adherence to eukaryotic cells and increasing susceptibility to antimicrobial 
peptides (25). Apart from D-alanylation, O-acetylation of peptidoglycan has also been 
reported as a cell wall modification that alters autolysis in some bacteria, including 
Enterococcus (7, 55, 85). The O-acetylation occurs at the C6 residue of N-acetylmuramic 
acid of the peptidoglycan (67)  in a growth phase dependent manner (85). There has been 
conflicting reports about the contribution of this modification to enterococcal lysis. It is 
reported by Pfeffer et al. (2006) and Jeune et al. (2010) that O-acetylation of 
peptidoglycan protects the cells from action of lysozymes and autolysis (57, 85) while 
Emerian et al. (2009) showed very marginal effect of this modification to cell lysis and 
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also suggested an increase in the activity of autolysin B in the absence of this 
modification (24). 
1.3 Carbon Metabolism in Enterococci 
Phosphoenolpyuruvate phosphotransferase systems (PTS) in Bacteria. 
 
Figure 1-1 Phosphotrasferase system in low GC Gram positive bacteria adapted 
from (27). 
 
Bacteria possess transport systems that facilitate the uptake of carbohydrates and their 
conversion to phosphosugars that feed into the catabolic pathway to generate energy. 
These transport systems are called phosphoenolpyruvate:carbohydrate 
phosphotransferase system or the PTS system. These are exclusive to the prokaryotes and 
have not been identified in eukaryotes. They were first discovered in Escherichia coli by 
Kundig, Ghosh and Roseman in 1964. They identified this novel system in their attempt 
to find an enzyme similar to mammalian kinases that are involved in metabolism of sialic 
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acids in bacteria (such as E.coli) that can metabolize N-acetyl-D-mannosamine. They 
showed that phosphoenolpyruvate (PEP) could phosphorylate different hexoses sugars 
such as glucose, mannose, glucosamine, mannosamine, N.acetylyglucosamine and N-
acetylmannosamine by sequential transfer of phosphate group (54). It is the 
phosphorylation and dephosphorylation of the PTS components that mediates the 
regulation of this system (Figure 1-1).  
Composition of PTS: 
The PTS components of both Gram negative and Gram positive organisms are 
very similar and consists of three main components, Enzymes I, Enzyme II and heat-
stable, histidine containing protein Hpr (87). Enzyme I and Hpr are cytoplasmic in nature. 
In general Enzyme II is multidomain protein with one/two (EIIC/EIID) hydrophobic 
integral membrane domain and two hydrophilic cytoplasmic domains (EIIB and EIIA). 
Enzyme I and Hpr are common to all the PTS carbohydrates however, enzyme II is 
specific and thus determines the specificity of a PTS system. Enzyme II is responsible to 
transport across the membrane and subsequently phosphorylates the sugar to feed into 
glycolysis. PTS systems are very diverse in nature due to the specificity bestowed upon 
them by the EII complex. On the basis of substrate specificity and phylogeny of EII’s, the 
PTS systems have been grouped into four families with lucid evolutionary origin and 
termed by the authors as ‘a snapshot of evolution in transition’ (96). The four families are 
(i) the glucose-fructose-lactose (Glu-Fru-Lac) superfamily, (ii) the ascorbate-galactitol 
(Asc-Gat) superfamily, (iii) the mannose (Man) family, and (iv) the dihydroxyacetone 
(Dha) family.  
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Enzyme I (EI) encoded by the gene pstI (EF0710) is 140 kDa containing 
homodimer protein that is phosphorylated at the conserved histidyl residue by the 
glycolytic intermediate phosphoenolpyruvate (PEP) (2) .  
Carbon catabolite repression 
The stringent regulation of carbon uptake by bacteria is termed as carbon 
catabolite repression (CCR). In the presence of preferred and easily metabolizable carbon 
source, bacteria prevent the expression of and function of catabolic systems that facilitate 
the use of secondary carbon source or secondary substrates thus exerting CCR. Being 
able to select the most energy rich carbon source that provides more energy and 
minimalizes the expenditure of the same is the basis of CCR. Being able to exert CCR 
provides bacteria an advantage in nature as well as in host environments because the 
ability to adapt and use the available nutrient source determines their survival in such 
environments. 
Carbon catabolite repression is globally regulated in both Gram-positive and 
Gram-negative bacteria and PTS systems play a key role in both systems (27). The oldest 
and the most studied system of CCR is the diauxic growth curve exhibited by E.coli when 
grown in media containing glucose and lactose (61). Diauxic refers to the sequential use 
of carbon source with a short lag period before switching from the readily metabolizable 
carbon source such as glucose to the secondary substrate i.e. lactose. In Gram negative 
bacteria (model organism E.coli), the main players in CCR regulation are (i) enzyme II 
(EII) of the PTS system (ii) the secondary messenger molecule cyclic adenosine 
monophosphate (cAMP) (iii) cyclic AMP receptor protein (CRP) which is a 
transcriptional activator (iv) the enzyme adenylate cyclase. The phosphorylation state of 
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EII influences CCR. In the presence of preferred carbon source, EII is dephosphorylated 
because it transfers the phosphoryl group to the sugar that can then enter glycolysis. 
Phosphorylated EII activates the membrane bound adenylate cyclase. Activation of 
adenylate cyclase leads to increased cAMP levels and thus to the formation of cAMP-
CRP complex. The cAMP-CRP complex binds to the promotors and activates the 
expression of catabolic genes (27).  
In low GC Gram positive organisms, the phosphorylation state of Hpr of the PTS 
plays a pivotal role in the global regulation of CCR. Other than Hpr, the catabolite 
control protein A or CcpA, and the glycolytic intermediates Fructose-1,6-bisphosphate 
and glucose-6-phosphate are the key mediators of CCR (120). Hpr protein can be 
phosphorylated at two positions (Ser 46 and His 15) and depending on which site gets 
phosphorylated; it either activates or alleviates CCR. E1 of the PTS phosphorylates Hpr 
at position His-15 (87). In the presence of favorable growth conditions, a bifunctional 
enzyme HPrK/P phosphorylates Hpr at Ser-46. P-Ser-Hpr binds to CcpA and forms a 
complex that bind to operator sites leading to CCR (86).  
1.4 Biofilm Formation  
Complex infections caused by enterococci are generally nosocomial in nature 
associated with implanted medical devices leading to surgical site infection, urinary tract 
infections, endocarditis and bacteremia. Biofilms are the source of most of these 
infections. Biofilm, in simple terms, is a congregation of bacteria held together by 
substances secreted by the bacteria and contributed by the environment. Biofilm 
formation occurs in four distinct stages with various players involved in each of these 
stages: attachment, recruitment, maturation and dispersion.  
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A mature biofilm consists of loosely packed clusters of cells called microcolonies 
that are held together by extracellular matrix components. These loosely held 
microcolonies are also interspersed with water channels that serve to transport nutrients 
in the deeper part of the biofilm (78).  In enterococci, dispersion of biofilms is an open 
area of research since very little is known regarding dispersal of enterococcal biofilms.  
The initiation of biofilm formation occurs when bacteria adhere to a biotic (native 
heart valves, urinary tracts etc.) or abiotic (polystyrene plate, prosthetic valves, catheters 
etc) surface. These surfaces, similar to the bacterial surface, carry a net negative charge 
under normal physiological conditions (122). Hence the bacteria (including enterococci) 
develop modifications on their outer surface to lower their surface negative charge to 
prevent electrostatic repulsion that hinder adherence surfaces. The correlation between 
the natural charge occurring on a bacterial surface and the number of ionizable groups 
exposed on the surface is termed as a zeta potential of the bacteria and is influenced by 
the pH and ionic strength in the environment. It has been shown that the heterogeneity of 
the zeta potential in an enterococcal population enhances adhesion of enterococci and a 
homogenous culture is attenuated in adhesion (122). Recently, the endocarditis and 
biofilm associated pili locus of E. faecalis OG1RF (ebp) has been shown to play a role in 
heterogeneity of zeta potential. Deletion of EbpR, the regulator of ebpABC operon 
resulted in a homogenous culture with the least negative zeta potential. Similar results 
were observed when the genes of ebp operon were deleted. The differential expression of 
ebp operon contributed to the heterogeneity of zeta potential in a population. Thus, in 
addition to a role in promoting physical adhesion while establishing an infection, Ebp 
indirectly contributes by governing the zeta potential of the bacteria cell (108). Besides 
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adhesion to the surface, cell-cell adhesion also plays an important role in biofilm 
development. Several enterococccal surface proteins containing the LPxTG anchoring 
motif such as aggregation substance (15, 52, 107), enterococcal surface protein (Esp) 
(111, 123), collagen binding proteins (Ace (51, 71), Acm (72, 73), Scm (105)), faecalis 
surface protein (fss) (104) and pili (Ebp (74), bee (100) , pilA and pilB (35)) aid in 
adhesion, influence biofilm formation and promote pathogenesis. LPxTG type proteins 
are a class of surface proteins that are characterized by the presence of LPxTG motif at 
the C-terminal that are recognized and cleaved by a transpeptidase enzyme called sortase. 
Upon cleavage, these enzymes covalently mobilize the surface protein to the 
peptidoglycan (22).  
Horizontal gene transfer is responsible for the acquisition of several virulence 
traits and antibiotic resistance by enterococci (81). One of the most prevalent forms of 
horizontal gene transfer is conjugation or transfer of genetic elements via physical 
contact.  Bacterial surface bound glycoprotein termed the aggregation substance mediates 
contact between donor and recipient cells during conjugation and thus enhances plasmid 
transfer. Aggregation substances are encoded by the plasmids carried by the donor cells 
in response to sex-pheromones secreted by the recipient cells (23, 126). Asa1 is an 
aggregation substance encoded by the plasmid pAD1.  In E. faecalis OG1X (pAD1) cells, 
Asa1 expression is induced by serum in addition to the pheromone secreted by the 
recipient cells suggesting a role beyond just plasmid transfer. Also, Asa1 contains an 
Arg-Gly-Asp-Ser motif similar to the fibronectin protein which binds eukaryotic cells. 
Giving credence to those observations, it was shown that Asa1 mediates bacterial 
adherence to renal tubular cells in addition to its known property to enhance bacterial 
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clumping for plasmid transfer (52). In addition to renal tubular cells, Ada1 was shown to 
augment adherence to  and survival in macrophages (107). Another aggregation 
substance Asc10 encoded by the plasmid pCF10 has also been implicated in adherence to 
host tissue. Similar to asa1 expression, mammalian bloodstream and growth on heart 
valves as a bacterial vegetation induced expression of the prgB gene encoding Asc10 
suggesting its importance in vivo (15).  Enterococcus faecalis was shown to bind porcine 
heart valves in both Asc10 dependent and independent fashion (15) although E. faecalis 
OG1Ssp (pCF10) strains expressing Asc10 were remarkably more virulent than the 
plasmid free counterpart in a rabbit model of endocarditis (16). The enterococcal surface 
protein (Esp) encoded by the esp gene on the pathogenicity island of E. faecalis enhances 
biofilm formation, although the presence of functional Esp is not absolutely required.  
Enhanced biofilm formation by Esp+ strains of E. faecalis could be attributed to 
increased adherence potential bestowed by the surface expression of Esp in those strains 
(65, 110, 121). Similarly, E. faecium also harbors a variant of the esp gene on its 
pathogenicity island (102) and its expression is temperature dependent with maximum 
expression observed at 37°C and under anaerobic conditions. Van Wamel et al. postulate 
this growth dependent expression of esp to be a niche dependent adaptation of E. 
faecium. Like E. faecalis, surface expression of Esp enhanced adherence to polystyrene 
plates and its ability to form a biofilms (123). The discrepancy about the contribution of 
Esp to adherence in E. faecalis also exists in E. faecium. Although Esp enhanced 
adherence of E. faecium to polystyrene plates, it was not essential for attachment to Caco-
2 cells and intestinal colonization in mice (33).  
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In normal eukaryotic tissue the extracellular matrix such as collagen, fibronectin 
and laminin are usually not exposed and are covered by the epithelial or endothelial cells. 
They are exposed in the event of trauma and become vulnerable to microbial 
colonization.  Several microrganisms have exploited these ECM for colonization and 
establishment of infection (60, 125). The enterococcal collagen binding MSCRAMM 
(Microbial Surface Component Recognizing Adhesive Matrix Molecules), Ace, promotes 
attachment of E. faecalis clinical isolates to collagen type I, type IV and laminin (71, 94). 
In E. faecalis OG1RF, the Ace dependent binding of bacterial cells to the ECM 
components is termed ‘conditional’ because the bacteria adhere to collagen and laminin 
only after incubation at 42°C and in ECM concentration dependent fashion (71). 
Although rare, E. faecalis has also been isolated from endodontic-treated root canals 
(133). Ace also mediates the binding of E. faecalis OG1RF to root canal dentin as the 
first step to establishing infection (51). 90% of root canal dentin is composed of Type I 
collagen (64). Similarly, a collagen binding adhesin in E. faecium (Acm) that shares 
homology with the A domain of E. faecalis Ace was detected in all the strains tested. 
However, only the clinical isolates of E. faecium harboring acm were found to bind type I 
collagen (75). It is also interesting to note that the presence of a functional acm gene was 
found to correlate with the hospital isolates of E. faecium CC17 suggesting that the 
adhesin Acm might have an important contribution in the emergence of E. faecium 
genogroup CC17 as a nosocomial pathogen (73). In addition to Acm, E. faecium also has 
second collagen binding adhesin Scm which binds efficiently to type V collagen in a 
concentration dependent manner (105). Recently two novel surface proteins have also 
been characterized in E. faecium that contributes to further enhance binding to host ECM. 
15 
 
A surface adhesion SgrA and another MSCRAMM called EcbA have been identified that 
enable binding to nidogen (I & II) and type V collagen respectively, apart from their 
contribution to fibrinogen binding (36). Three enterococcal surface proteins that are 
structurally and functionally similar to staphylococcal MSCRAMMs have been identified 
in E. faecalis V583. They are termed as faecalis surface proteins fss1, fss2 and fss3 also 
promote adherence to fibrinogen when enterococci are grown in serum supplemented 
media (104) suggesting that in-vivo, several host components trigger adaptation in 
eneterococci that enable them initiate colonization. 
1.5 Quorum Sensing in Enterococci. 
Cell density dependent signaling also termed as quorum sensing influences the 
behavioral changes that benefit the bacteria and also serve in the maturation of the 
biofilm on the basis of a cascade of genetic and hence phenotypic changes that occur as a 
result of quorum signaling (45). In E. faecalis, a gene cluster homologous to 
Staphylococcusaureus agr locus, called the fsr locus regulates the cell density dependent 
signaling cascade (69, 92). The fsr locus is comprised of four genes fsrA, fsrB, fsr D and 
fsrC. FsrA and FsrC constitute a two component signal transduction system with FsrC 
being the membrane localized sensor kinase while FsrA being the cytoplasmic response 
regulator. The C- terminus of FsrD encodes an 11 residue long quorum signaling 
molecule called the gelatinase biosynthesis activation pheromone (GBAP) which is 
processed and secreted by the membrane bound enzyme FsrB (70, 92). Once the 
concentration of GBAP in external milieu of the cell reaches a threshold value, GBAP 
binds to and activates FsrC which in turn activates the response regulator FsrA. 
Differential expression of over 300 genes is regulated by the activated FsrA. Most of 
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these genes are involved in other regulatory cascades, metabolism and virulence (11). 
Downstream the fsr locus and transcriptionally regulated by the same are two genes that 
encode the extracellular proteases, gelatinase (gelE) and serine proteinase (sprE) (93). 
The fsr system plays a pivotal role in enterococcal biofilm formation (30, 66). Hancock 
and Perego (2004) showed that mutation in gelE diminishes biofilm formation and thus 
fsr regulates biofilm formation via the downstream protease gelatinase (30). It has also 
been shown that the growth of fsr mutants in media supplemented with physiological 
concentrations of GelE restored biofilm formation by the fsr mutant (30). Death of a 
small population of cells is an important event for biofilm formation because cell death 
contributes extracellular DNA which is a key matrix component that binds the biofilm 
together (26). Thomas et al. (2008) showed that GelE contributed to biofilm formation by 
promoting cell death and providing eDNA. Using DNase I treatment of biofilms and 
confocal microscopy of gelE mutant biofilms, absence of eDNA was shown to correlate 
with the biofilm defect (118). They also proposed a fratricidal model of eDNA release 
where one population of cells that doesn’t respond to the quorum is killed by the other 
population and supported the existence of heterogeneity in a single species population 
(117). Barnes et. al (2012) confirmed the presence of eDNA during early stages of 
biofilm formation  however they suggest a cell death independent mechanism for eDNA 
release because eDNA was found in well-defined structures throughout the biofilm (5). 
Interestingly, fsr regulation of biofilm formation in gelE independent fashion has also 
been reported(66). It could be attributed to the role of environmental cues. Several studies 
have shown that nutrient factors such as glucose influence biofilm development in 
different organisms, including Enterococcus. (59, 106, 110). A study reported the 
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involvement of putative maltose specific PTS encoding genetic loci bopABCD (56) in 
enterococcal biofilm formation and bacteremia in mice (11, 42). They showed that BopD 
which is a sugar binding transcriptional regulator was essential for biofilm formation and 
was present in all biofilm-positive strains of E. faecalis (42).   
1.6 RpoN 
Controlled regulation of transcription initiation is one of the important stages of 
gene expression that plays a crucial role in helping an organism adapt to changing 
environmental conditions in addition to its general housekeeping functions. RNA 
polymerase core enzyme (cRNAP) that consists of various subunits (α2, β, β’, ω) 
efficiently performs transcription in eubacteria inorder to accurately synthesize RNA and 
facilitate transcription termination. In prokaryotes, the evolutionarily conserved and 
cRNAP requires the binding of a dissociable sigma (σ) factor in order to identify the 
promoter specific DNA sequence and aid transcription initiation. The complex formed by 
the binding of cRNAP and σ is called the holoenzyme. Two distinct families of sigma 
factors have been identified on the basis of their protein homology. They have been 
named on the basis of their molecular weights as sigma 70 (σ70) and sigma 54 (σ54; 
RpoN) (129). The formation of holoenzyme strictly requires the dissociable σ subunit and 
hence the number of sigma factors possessed by organisms varies according to their 
environmental niche and their growth requirement. For example the Gram negative 
pathogen Pseudomonas aeruginosa  has 24 sigma factors, some of which do not have a 
defined function (89). The  σ70  family of transcription regulators are abundant in most 
bacterial genomes. They direct RNA polymerase to specific promoter elements located 
between the -10 and -35 position upstream of the initiation start site of the gene. The σ70 
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family also includes several related alternate sigma factors that are classified on the basis 
of their genetic structure and function. Sigma 70 controls the expression of most genes 
during the exponential growth phase and its related sigma factors have been associated 
with regulation of genes in response to specific environmental signals such as stress, 
sporulation, heat shock , presence of misfolded proteins etc.  (79). Structurally divergent 
to sigma 70 are σ54 family of transcription regulators. They recognize a distinct consensus 
binding sequence (TTGGCACNNNNNTTGCT) located at -24/-12 position upstream the 
initiation site (32, 63). One of the most striking difference between the two sigma factors 
is the way they initiate transcription. Once RNAP-sigma70 bind to the promoter 
consensus sequence at the -10/-35 position upstream the start site, it spontaneously 
triggers opening of the DNA  and initiates transcription (79) . In contrast, once RNAP 
coupled to sigma54 binds to the promoter consensus sequence at -12/-24 position, it 
continuous to be in a closed inactive complex. For this inactive complex to open and for 
transcription to begin, the RNAP-sigma54 holoenzyme requires the interaction with 
activator proteins. Thus the initiation of transcription by sigma54 is termed to be activator 
dependent(63). The activator proteins that couple with RNAP-sigma54 holoenzyme are 
members of AAA (ATPase Associated with various cellular Activities) protein family 
that aid conformational changes for the active open complex formation using energy 
derived by ATP hydrolysis (101). In this dissertation, we restrict to σ54 family of 
transcription regulators. 
Domain Organization of RpoN 
In E. faecalis V583, sigma 54 or RpoN is a 447 amino acid long protein encoded 
by the gene ef0782 on the chromosome.  On the basis of data available regarding the 
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structure-function relationship, the protein is made up of three regions. Region I, Region 
II and Region III (Figure 1-2). The N-terminal region I is responsible for interaction with 
activator proteins to promote transcription initiation by forming an open complex. Region 
II strongly binds to RNA polymerase while region III is designated for DNA binding (8, 
14, 127). The highly conserved 10 amino acid sequence (ARRTVAKYRE) at the C 
terminal end of RpoN in region III adopts an alpha helical structure. Mutational analysis 
attributed the function of promoter recognition by RpoN to this conserved sequence and 
it is termed as the’RpoN Box’(109). The C-terminal end of RpoN which contains the 
highly conserved RpoN box shares structural homology to the σ3 and σ4 domains of σ70 
This structural homology is interesting because there exists no sequence similarity 
between the two. Preceding the RpoN box is an unpredicted helix turn helix motif that 
enhances the binding of RpoN box to the -12/-24 consensus sequence (21). 
 
 
Figure 1-2 Domain Organization in RpoN. 
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Role of RpoN in other bacteria 
RpoN plays an important role in the virulence of several bacteria but does not 
share the same function in all pathogens (48). In the biology of Vibrio species, rpoN 
regulates several diverse functions which include motility, biofilm formation, and 
quorum sensing, luminescence and host colonization. In the fish pathogen V. 
alginolyticus, RpoN and the enhancer binding protein VasH along with the quorum 
regulator LuxR govern the expression of the genes involved in type 6 secretion system 
(T6SS). RpoN and VasH are also required for the expression of hemolysin regulated 
protein Hcp1 which is a hallmark for T6SS (103). Similarly in V.cholerae, expression of 
hcp which is regulated by quorum sensing requires functional RpoN. The quorum sensing 
regulator HapR positively regulates the expression of hcp and in an rpoN mutant 
expression of hcp was completely abolished despite the increased levels of HapR 
indicating that RpoN controls the expression of hcp in  HapR-independent manner (46). 
In  V.fischeri, RpoN regulates the activation of flagellar genes, influences biofilm 
formation and initial colonization of squids in a flagella independent fashion (91). The 
rpoN mutant in V.fischeri has no growth defect in rich medium and glucose supplemented 
minimal media (MM-G) that contain casamino acid, ammonium chloride and/or 
glutamine. However, in MM-G that contains serine as the sole source of nitrogen, the 
mutant is attenuated in growth suggesting the requirement of RpoN in nitrogen limiting 
conditions.  In Bacillus subtilis, the sigma 54 equivalent SigL regulates the transcription 
of levanase operon and sigL mutants exhibit growth defect in media containing valine, 
ornithine, isoleucine or arginine as the sole nitrogen source (20). A seven gene operon, 
bkd, involved in the deamination of isoleucine and valine and degradation of branched 
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chain alpha keto acids in B.subtilis is also regulated by SigL along with the transcription 
activator BkdR (19). Sigma 54 is required for biofilm formation by Burkholderia 
cenocepacia as well as survival within macrophages (97). In the Listeria monocytogenes, 
RpoN regulates osmotolerance (77) and is responsible for mesentericin sensitivity (18, 
77) whereas in Pseudomonas aeruginosa, it influences the activity of isocitrate lyase, 
alginate biosynthesis (10, 28) and in pilin and flagellin production in addition to several 
other virulence determinants (88). Sigma 54 also regulates biofilm formation, enterocyte 
effacement, acid tolerance, flagellar biosynthesis and several other processes in E. coli (6, 
95, 134).  
 RpoN in Enterococcus 
In E. faecalis, RpoN is responsible for sensitivity to Class IIa bacteriocins such as 
mesentericin and divercin (13, 17).  The basis for the Class IIa bacteriocin sensitivity is 
due to the role of σ54 in regulating mannose sugar uptake system with the help of the 
enhancer binding protein MptR. In addition to mannose three distinct sugar 
phosphotransferase (PTS) systems with RpoN recognition sequence upstream the 
putative operons and their respective enhancer binding proteins LpoR, MphR and MpoR 
have been identified (32).  
The focus of this dissertation is to understand the role of RpoN in the different 
aspects of enterococcal biology such as biofilm development, metabolism and its impact 
of virulence. 
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Chapter 2 -  Deletion of σ(54) (rpoN) alters the 
rate of autolysis and biofilm formation in 
Enterococcus faecalis. 
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2.1 Abstract 
Transcription initiation is a critical step in bacterial gene regulation and is often 
controlled by transcription regulators. The alternate sigma factor (RpoN) is one such 
regulator that facilitates activator dependent transcription initiation and thus modulates 
the expression of a variety of genes involved in metabolism and pathogenesis in bacteria. 
This study describes the role of RpoN in the nosocomial pathogen, Enterococcus faecalis.  
Biofilm formation is one of the important pathogenic mechanisms of E. faecalis that 
elevates its potential to cause surgical site and urinary tract infections. Lysis of bacterial 
cells within the population contributes to biofilm formation by providing eDNA as a key 
component of the biofilm matrix. Deletion of rpoN rendered E. faecalis resistant to 
autolysis which in turn impaired eDNA release. Despite the absence of eDNA, the rpoN 
mutant formed robust biofilms as observed using laser scanning confocal microscopy 
indicating and emphasizing the presence of other matrix components. Initial adherence to 
polystyrene plate was enhanced in the mutant. Proteinase K treatment of biofilm at 
different stages of development significantly reduced the accumulation of biofilm by the 
rpoN mutant. In conclusion, our data indicates the presence of proteins as an additional 
matrix component in E. faecalis V583 biofilms and suggests a regulatory role of RpoN in 
governing the nature and composition of the biofilm matrix. 
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2.2 Introduction 
As opportunistic pathogens, enterococci, are the third leading cause of  hospital 
acquired or associated infections responsible for 11.2 % surgical site infection (SSI), 
14.9% of urinary tract infection (UTI) and 16% of the reported blood stream infections 
(25). The ability to form biofilm is an important aspect of the lifestyle of the organism as 
biofilm formation is thought to be a property associated with the establishment of SSI and 
UTI (34) both of which serve as foci to establish blood stream infections. Biofilms are 
aggregates of bacteria that are covered in exoploymer matrix and are more resistant to 
antibiotics than their planktonic counterparts (15, 26). In several bacterial species nucleic 
acids, polysaccharides, proteins and lipids constitute the exopolymer matrix (19). The 
components of the biofilm matrix form a physical barrier that enhance the inaccessibility 
of the biofilm cells to antibiotics and the immune system thereby making the infection 
difficult to eradicate (33).  Extracellular DNA (eDNA) serves as an important biofilm 
matrix component in several microbial model systems including but not limited to 
Neisseria meningitidis, Listeriamonocytogenes, Pseudomonas aeruginosa, E. faecalis, 
Staphylococcusaureus and S.epidermidis (2, 23, 29, 32, 36, 47, 48, 54). The expression of 
the two secreted E. faecalis proteases, gelatinase and serine protease, is regulated in a 
quorum-dependent manner by the Fsr regulatory system (22, 45, 46), and these proteases 
direct biofilm development by modulating the eDNA matrix by regulating the extent of 
autolysis (54) in a fratricidal manner (51). In an attempt to identify other factors that 
govern eDNA release in E. faecalis, we identified rpoN which encodes σ54 in a 
preliminary transposon mutagenesis screen.  
Transcription initiation is one of the important stages of gene regulation and 
sigma factors play a crucial role in determining the controlled response of a subset of 
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genes tied to a given environmental stimulus.  Sigma factors reversibly bind to RNA 
polymerases and drive promoter specific transcription initiation. In prokaryotes, two 
distinct families of sigma factors have been studied, sigma 70 (σ70) and sigma 54 (σ54). 
The σ70 family also includes several related alternate sigma factors. Sigma 54 shares no 
structural homology with sigma 70, possesses a distinct consensus binding sequence (-
24/-12;TTGGCACNNNNNTTGCT) and unlike sigma 70, facilitates activator dependent 
transcription initiation (24, 38). 
Sigma 54 plays an important role in the virulence of several bacteria but does not 
share the same function in all pathogens (30). In Vibrio fischeri, σ54 influences biofilm 
formation, motility and symbiotic colonization of squids and negatively regulates 
bioluminescence (58). Quorum sensing regulation in V. cholerae O1 strains is dependent 
on rpoN (28). Sigma 54 is required for biofilm formation by Burkholderia cenocepacia as 
well as survival within macrophages (51). In the major food-borne pathogen Listeria 
monocytogenes , σ54 is essential for its osmotolerance potential (42) and is responsible for 
mesentericin sensitivity (14, 42) whereas in Pseudomonas aeruginosa, σ54 influences the 
activity of isocitrate lyase (21) , alginate biosynthesis (6) and in pilin and flagellin 
production in addition to several other virulence determinants (44). Sigma 54 also 
regulates biofilm formation, enterocyte effacement, acid tolerance, flagellar biosynthesis 
and several other processes in E. coli (3, 49, 60).  
In E. faecalis, σ54 is responsible for sensitivity to class IIa bacteriocins such as 
mesentericin and divercin (9, 13).  The basis for the class IIa bacteriocin sensitivity is due 
to the role of σ54 in regulating four distinct sugar phosphotransferase (PTS) systems that 
are dependent on four known σ54 enhancer binding proteins (LpoR, MphR, MpoR, and 
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MptR) (13) .  MptD, a component of the mannose PTS system is thought to serve as the 
cellular receptor for the class IIa bacteriocins (24). However, additional roles for σ54 in 
enterococcal biology remain to be elucidated. 
In this study, we investigate the role of σ54 in eDNA release, autolysis and biofilm 
formation and demonstrate a functional role for σ54 in regulating initial adherence of cells 
to substrate as well as the overall composition of the biofilm matrix. 
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2.3 Materials and Method 
Bacterial strains and growth conditions: 
The bacterial strains and plasmids used in this study are listed in Tables 1 and 2 
respectively. Escherichia coli Electroten Blue (Strategene) was used for construction of 
plasmids and was cultured in Luria-Bertani (LB) broth supplemented with appropriate 
antibiotics.  Enterococcus faecalis strains were cultured in Todd-Hewitt broth (THB; BD 
Biosciences) containing appropriate antibiotics whenever required.  Chloramphenicol 
(Cm) and spectinomycin (Spec) were used for selection of E. coli at a concentration of 
10µg/ml and 150µg/ml respectively.  For E. faecalis, Cm, Spec and tetracycline (Tet) 
were used at 15µg/ml, 500µg/ml and 15µg/ml respectively.   
Table 2-1 Enterococcus faecalis strains used in this study 
 
When required, X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside; AMRESCO) 
was used at a concentration of 80µg/ml for both E. coli and E. faecalis.  
In-frame Markerless deletion of rpoN 
An E.coli-enterococcal temperature sensitive cloning vector,pLT06  (56), was 
used to generate isogenic  in-frame deletion of rpoN in E. faecalis V583. Upstream and 
downstream regions flanking rpoN (EF0782) were amplified by PCR from a V583 
Strain  Genotype; Relevant Phenotype Reference 
V583 Parental Strain Clinical isolate (50) 
VI01 V583ΔrpoN This Study 
VI40 VI01 full length rpoN markerless complement This study 
VT09 V583 (pMV158GFP) Gfp, Tet
R
 (54) 
VI29 VI01 (pMV158GFP) Gfp, Tet
R
 This Study 
VI41 VI40 (pMV158GFP) Gfp, Tet
R
 This Study 
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genomic template using the primer pair RpoNP1/RpoNP2 and RpoNP3/RpoNP4 
respectively (Table 2-3). The primers RpoNP1/RpoNP2 and RpoNP3/RpoNP4 were 
designed with EcoRI/BamHI and BamHI/PstI restriction sites respectively. The resultant 
PCR products were digested with BamHI, ligated and re-amplified with primers RpoNP1 
and RpoNP4. For the construction of the deletion vector, the amplified product was 
digested with EcoRI and PstI followed by ligation to similarly digested pLT06. The 
ligation was electroporated into competent E10-Blue cells for propagation and blue 
colonies were selected on LB agar containing chloramphenicol and X-Gal at 30°C.  
Clones were screened for the appropriate insert using the primers OriF and SeqR. A 
positive plasmid designated pKS70 was confirmed by restriction digest and 
electroporated into E. faecalis V583 cells (12) and VI01 was subsequently generated 
following the protocol previously described (56) and confirmed by PCR using primers 
RpoNUp and RpoNDown. Using pKS70, ~ 98% of the  rpoN gene was deleted leaving 
seven codons at the 5’ end and two codons at the 3’ end.  The next adjacent gene is 
ef0783, which encodes an O-acetyltransferase.  This gene is located approximately 200 
bps downstream of rpoN and the strategy used to delete rpoN does not alter the 
expression of ef0783 (data not shown). 
Table 2-2 Plasmid Constructs used in this study. 
Plasmid Description Reference 
pLT06 Deletion vector; chloramphenicol resistance. (56) 
pKS70 
pLT06 containing engineered rpoN deletion (2kb  
EcoRI/PstI fragment)  
This study. 
pVI12 pLT06 containing full length rpoN  This study. 
pMV158GFP Gram-positive replicative vector: Gfp; Tet
R
 (1) 
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Markerless Complementation of VI01 [ΔrpoN] 
The temperature sensitive cloning vector pLT06 (56), was used to generate 
markerless gene complementation of rpoN in VI01. The rpoN gene (EF0782) along with 
flanking regions was amplified by PCR from a V583 genomic template using primers 
RpoNP1 and RpoNP4 (Table 2-3). For the construction of rpoN markerless 
complementation vector pVI12, the amplified product was digested with EcoRI and PstI 
followed by ligation with similarly digested plasmid vector pLT06.  The ligation was 
electroporated into competent E10-Blue cells for propagation and blue colonies were 
selected on LB agar containing chloramphenicol and X-Gal at room temperature.  Clones 
were screened for the appropriate insert using the primers OriF and SeqR. A positive 
plasmid designated pVI12 was confirmed by restriction digest and electroporated into E. 
faecalis VI01 cells (12) and VI40 (markerless complement) was generated following the 
protocol previously described (56) and confirmed by PCR using primers RpoNUp and 
RpoNDown. 
2-Deoxy-D-Glucose (2DG) resistance 
Enterococcus faecalis V583, VI01 and VI40 were grown on LB agar containing 
0.2% fructose and 10 mM 2-Deoxy-glucose (2DG) (24). 2DG is a toxic homologue of 
glucose and enters the cells via the mannose PTS permease (5).  In E. faecalis, the 
mannose PTS expression is controlled by σ54. Strains resistant to 2DG do not express a 
functional mannose PTS permease (24). Hence growth on media containing 2DG was 
used as a marker to confirm deletion of rpoN. 
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       Table 2-3 Oligonucleotides used in this study. 
Detection and precipitation of extracellular DNA  
Overnight cultures were centrifuged for 10 minutes at 13,000 rpm and the 
resulting supernatant filtered (0.2 µm pore size; Nalgene) to obtain cell free supernatants.  
The supernatants were tested for the presence of e-DNA using 1μM SYTOX® Green 
(Invitrogen, Molecular Probes). 
The eDNA was also precipitated from the culture filtrate using an equal volume 
of isopropanol. The precipitated eDNA was washed in 75% ethanol, air-dried and 
dissolved in TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 8.0) and visualized on 1% 
agarose gels after staining with ethidium bromide. 
Autolysis Assay 
Autolysis assay was performed as previously described (15).  
Quantitative Detection of eDNA in Biofilm 
eDNA in biofilm was quantified using a previously described protocol (36). 
Briefly, biofilms were grown in 96-well polystyrene plate in TSB for 24 hrs at 37°C. 
 Primers Sequence (5’-3’) 
RpoNP1 GAGAGAATTCACAACGGTACAGTAAAATGG 
RpoNP2 CTCTGGAATCCCATTCGTTGCTCAAATTTCAT 
RpoNP3 GAGAGGATCCGAGTAAACAACCAAAGATTAT 
RpoNP4 CTCTCTGCAGGAACTAAGGCACTTAAACCA 
RpoN UP AGTCCAAGGAAGAGTCGTG 
RpoN 
DOWN 
AAGACAGTGGCTGCCAAAC 
OriF CAATAATCGCATCCGATTGCA 
SeqR CCTATTATACCATATTTTGGAC 
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After 24 hrs the supernatant was discarded and the biofilm was re-suspended in 
resuspension buffer (50 mM Tris-Cl pH 8, 10 mM EDTA, 500 mM NaCl). The 
resuspended biofilm was centrifuged and eDNA was quantified in the supernatant using 
1μM SYTOX® Green (Invitrogen, Molecular Probes). 
Confocal Laser Scanning Microscopy (CLSM) 
CLSM was performed on one-day old biofilms as described previously (54). 
Enterococcus faecalis strains VI01 and VI40 were transformed with pMV158GFP (39) to 
generate VI29 and VI41, respectively, and both express Gfp constitutively. VT09 [V583 
(pMV158GFP)] (54) along with VI29 and VI41 were used for confocal imaging. Briefly, 
biofilms were grown on sterile glass coverslips placed in six-well tissue culture plates. 
The coverslip was submerged in 5ml of TSB broth containing tetracycline for plasmid 
maintenance. After 24 hrs of growth, the biofilm was gently washed with sterile 
phosphate buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM 
KH2PO4 pH 7.4) and stained with 1μM SYTOX Orange
®  
( Invitrogen ) for 6 to 7 
minutes. The coverslip were inverted on a clean glass slide and sealed using clear nail 
polish. The biofilm was visualized using Zeiss LSM 5 Pascal laser scanning confocal 
microscope. 
Macroscopic Biofilm 
To visualize the biofilms formed by VT09, VI29 and VI41 macroscopically, 
biofilms were grown as per confocal analysis, with the exception that after 24 hours of 
growth, the biofilms were gently washed with sterile phosphate buffer and then fresh 
TSB was added, and the biofilms were grown for an additional 24 hours, at which time 
the biofilm was washed and imaged with a document camera. 
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Adherence Assay 
Adherence of E. faecalis strains to polystyrene plates was tested using a 
previously described protocol (27) with some modification. Overnight grown cultures 
were diluted 1:10 in fresh TSB and 200μl was transferred to a flat bottom 96 well 
polystyrene microtiter plates. After 2 hrs of incubation at 37°C, the supernatant was 
discarded and the wells were gently washed with sterile PBS. The adherent cells were 
resuspended in 200µl PBS by vigorous pipetting, diluted and plated on THB agar for 
colony counting. Also, the initial load was calculated by plating the diluted culture on 
THB agar for colony counting. The adherence potential of the strains was calculated as 
the percentage of initial load that adhered. 
Proteinase K treatment of Biofilm 
Biofilm were grown on 96 well polystyrene plates as previously described (22). 
At 6-, 12-, and 24-hr time points, the biofilm were treated with 1µg/ml proteinase K 
(Amresco). An untreated control was included to determine the effect of treatment. After 
24 hrs of growth, the biofilm was quantified with the crystal violet staining method (22). 
Each assay was performed in triplicate and repeated four times.  
Statistical Analysis  
Statistical analysis of quantitative detection of eDNA, adherence assay and 
comstat analysis of biofilm was performed using GraphPad Prism 4 software (San Diego, 
CA).  One way analysis of variance followed by Dunn’s multiple comparison tests was 
performed to determine statistical significance. 
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2.4 Results 
Construction of the E. faecalis V583 isogenic rpoN mutant and its 
complement   
The rpoN deletion mutant VI01 [ΔrpoN] was constructed using the markerless 
deletion vector pKS70.  The 2DG resistant phenotype was confirmed by growth on media 
containing 2DG.  VI01 grew to the final dilution of 10
-8
, whilst the parental strain V583 
and the rpoN complement VI40 were significantly inhibited and grew only at a dilution 
of 10
-3
 and 10
-4
.  Complementation confirmed that there were no polar effects of the gene 
deletion and attributed the 2DG resistant phenotype to the targeted deletion of rpoN 
(Figure 2-1). 
                                            
Figure 2-1 2-Deoxy-D-Glucose (2DG) resistance analysis of VI01 
Wild type strain, V583, (a) and the complement strain VI40 (c) are sensitive to 
2DG because of functional mpt operon under the control of intact rpoN. The rpoN mutant 
VI01 (b) is resistant to 2DG. This confirms the deletion and complementation of rpoN in 
E. faecalis. 
Sigma 54 alters eDNA release in the supernatant of planktonic and biofilm 
cultures. 
On the basis of phenotype characterization of a preliminary transposon 
mutagenesis screen, we tested for eDNA in the supernatants of planktonic cultures using 
SYTOX green. A lower amount of eDNA was detected in VI01 culture supernatant in 
comparison to the wild type V583 strain whereas the markerless complementation of 
rpoN mutant restored the phenotype to wild type levels (Figure 2-2 A). eDNA in the 
 b 
 c 
 a 
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supernatants of the various strains was also confirmed by visualization on an EtBr-stained 
1% agarose gel after precipitation of eDNA with isopropanol (Figure 2-2 B). Given the 
fact that planktonic growth and biofilm are two different lifestyles of the bacteria, we 
tested to see the effect of rpoN deletion on eDNA during biofilm development. As 
observed in planktonic cultures, a lesser amount of eDNA was detected in VI01 biofilm 
than the wild type which was attributed to the deletion of rpoN as the complementation 
restored the eDNA detected in the biofilm to wild type levels (Figure 2-2 C)  
Sigma 54 alters the rate of autolysis in E. faecalis V583. 
Because eDNA release in E. faecalis is dependant upon cell death by autolysis 
(54) and the rpoN mutant is defective in eDNA release, we hypothesized that σ54 may 
differentially modify the rate of autolysis in E. faecalis. In the autolysis assay, we 
observed that VI01 showed a significant decrease in the rate of autolysis, a phenotype 
readily complemented by introducing the gene in single copy to its native locus (Figure 
2-3). 
Sigma 54 alters the biofilm development of E. faecalis 
eDNA has been shown to be an important matrix component in E. faecalis biofilm 
(54). The decreased levels of eDNA in VI01 led us to the hypothesis that VI01 may form 
less dense biofilm in comparison to the wild type V583. However, CLSM analysis of 24 
hr old biofilm grown on glass coverslip showed that VI29 [ΔrpoN, Gfp+] formed thicker 
biofilm (as measured by the Z stack thickness using LSM image examiner) than those 
formed by the wild type strain VT09 or the complement strain VI41 (Figure 2-4II and 
Table 2-4).   
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Figure 2-2 Extracellular DNA detection 
A) Quantitative detection of eDNA in culture supernatants using SYTOX green. eDNA 
was quantified in the culture supernatants of overnight grown cultures using 1µM 
SYTOX green. Assays were performed in quadruplets and error bars indicate the 
standard error of mean. , significant P values of less than 0.001 relative to wild type 
V583; ф, significant P values of less than 0.001 relative to rpoN complement (VI40). B) 
Qualitative detection of eDNA in culture supernatant by isoporpanol precipitation. a, 
Wildtype (V583); b. rpoN mutant (VI01); c. rpoN complement (VI40). C) Detection of 
eDNA in biofilm using SYTOX green. Assays were performed in sextuplets and error 
bars indicate standard error or mean. , significant P values of less than 0.001 relative to 
wild type V583; δ, significant P values of less than 0.001 relative to rpoN complement 
(VI40). 
 
 
V583 VI01 VI40
0
100000
200000
300000
F
lu
o
r
e
s
c
e
n
c
e
A 
B 
V583 VI01 VI40
0
20000
40000
60000
F
lu
o
r
e
s
c
e
n
c
e
12 kb 
a b c 
C 
47 
 
The appearance of the VI29 biofilm suggested early initiation of microcolony 
development, which was confirmed by macroscopic examination of the biofilms after 2 
days growth on coverslips (Figure 2-4I).  Despite the increased thickness and overall 
biofilm biomass of the rpoN mutant [VI29] compared to the parental and complemented 
strains (Figure 2-4), very few random dead cells and DNA (as detected by SYTOX 
Orange staining) were observed within the biofilm. Consistent with earlier observations 
on the role of cell death and eDNA as a matrix component (54), regions within the wild 
type VT09 contained concentrated foci of  DNA and dead cells, which was phenocopied 
by the complement strain VI41 (Figure 2-4II). 
                  
Figure 2-3 RpoN alters the rate of autolysis in E. faecalis 
RpoN alters rate of autolysis in E. faecalis. Difference in autolysis rates of wild type 
(V583), rpoN mutant (VI01) and complemented strain (VI40) are plotted as percent of 
initial optical density at 600 nm. Assays were performed in triplicates and repeated four 
times; error bars represent standard error of mean. 
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Figure 2-4 E. faecalis Biofilm Analysis 
I) Macroscopic view of biofilm grown on glass coverslip. Biofilms were grown on glass 
coverslip in TSB media. A : VT09 ; B: VI29 ; C: VI41 
II) Confocal analysis of 1-day old biofilms grown on glass coverslip. The wild type, 
mutant and complement constitutively express Gfp from pMV158gfp as mentioned in 
materials and methods. Biofilms were grown on glass coverslips in TSB media. Dead 
cells and eDNA were stained with SYTOX orange (1µM). Live bacteria appear green 
while dead cells and eDNA are red. Panel A, B and C represent biofilm orthogonal 
projections for VT09, VI29 and VI41 respectively, exhibiting merged green and red 
staining.  Panel D, E and F correspond to dead cell and eDNA staining in VT09, VI29 
and VI41 biofilm respectively (matched pair to biofilms in Panel A, B and C). The scale 
bar represents 10 µm. 
. 
A B C 
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Table 2-4 Comstat Analysis of one-day old biofilms 
Deletion of rpoN increases adherence to polystyrene plates  
In order to determine whether increased biofilm formation by the rpoN mutant 
was due to its initial adherence ability, we calculated the percentage of initial inoculum 
that adhered to 96 well microtiter plates after two hours. Adherence of VI01 to a 
polystyrene plate was significantly enhanced in comparison to the wild type. In addition, 
complementation of VI01 reduced the adherence potential to wild type levels (Figure 
2-5). 
Sigma 54 modulates the composition of E. faecalis V583 biofilm. 
On the basis of the macroscopic observation and CLSM of the VI29 biofilm and 
the relative lack of eDNA detection in this mutant, we hypothesized a role for a different 
polymer matrix that promotes biofilm formation in the rpoN mutant.  To test the role of 
proteins in VI01 biofilm, we examined the effect of Proteinase K treatment on biofilm 
development. The wild type and complemented strain exhibited decreased biofilm when 
treated with proteinase K only after 24 hr of biofilm growth. In contrast, reduction in 
VI01 biofilm was significant when treated with proteinase K after 6 hr biofilm growth 
and continued to respond to treatment after 12 hr and 24 hr of biofilm growth. (Figure 
1-1Figure 2-6)  
Strain 
Mean ± SD 
Biomass (μm3 / μm2 ) Average Thickness  (μm) 
VT09 
 
2.09 ± 0.522 § 2.40 ± 0.589 § 
VI29             4.723 ± 1.28 5.97 ± 2.01 
VI41 2.19 ± 0.638 § 2.14 ± 0.624 § 
§, significant p-value of less than 0.05 in comparison to VI29 
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Figure 2-5 Adherence of E. faecalis on Polystyrene plate. 
Deletion of rpoN increases adherence of E. faecalis to 96-well polystyrene plates. , 
significant P values of less than 0.05 relative to wild type V583; ф, significant P values 
of less than 0.05 relative to rpoN complement (VI40) 
 
 
Figure 2-6 Proteinase K inhibits biofilm development of rpoN mutant on polystyrene 
plates. 
Biofilms were seeded at time zero for V583, VI01, and VI40 and the untreated biofilms 
were stained 24 hours later.  At the indicated times, proteinase K (1µg/ml) was added at 
either 6, 12, or 24 hours after seeding the biofilm, and the treatment was allowed to stand 
for the reminder of the assay.  Each assay was performed in triplicate and repeated four 
times.  Error bars indicate standard error of the mean.    
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2.5 Discussion  
The role of σ54 in regulating numerous biological properties, including those that 
relate to virulence has been well documented in a variety of bacterial species (3, 10, 21, 
41, 49, 51, 52, 55, 58, 59). However its role in E. faecalis has been limited to 
observations made regarding its contribution to sensitivity to class IIa bacteriocins 
through the regulation of sugar PTS systems (9, 13, 22). Identification of σ54 as a 
potential regulatory protein in the cascade of biofilm development was an interesting 
breakthrough and we focused our efforts on elucidating its affect on E. faecalis V583 
biofilm. The role of autolysis (54) and fratricide (53) has been well documented in 
enterococcal biofilm formation and has been shown to be important in providing eDNA 
as a key biofilm matrix component.  However, the observation that biofilm formation was 
enhanced in the rpoN mutant despite the increased resistance to autolysis and the absence 
of eDNA was an unexpected finding.  
One possible explanation for increased resistance to autolysis observed in the 
rpoN mutant could be novel modifications of the cell wall or altering the modifications 
such as O-acetylation (43) or D-alanylation (17) on the cell wall that protect against lysis. 
Deletion of rpoN did not alter the autolysin profile of E. faecalis when using micrococcal 
cell wall as a zymoGram substrate (data not shown) ruling out the possibility of inactive 
autolysins. Also, the deletion of rpoN does not have a measurable affect on the secretion 
of the extracellular proteases, GelE and SprE, which have been previously shown to 
contribute to autolysis in E. faecalis (54, 57) (data not shown). A significant reduction in 
cell death due to impaired cell lysis occurred in E. faecalis V583 ΔrpoN planktonic and 
biofilm cultures suggesting the requirement of a functional σ54 to regulate susceptibility 
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to cell lysis.  In P. aeruginosa, deletion of rpoN abolishes cell death in the microcolonies 
during biofilm maturation and has been related to the expression of surface structures 
(Type 4 pili and flagella) whose expression is regulated by σ54 (56).  Additionally, σ54 
dependent gene regulation promotes phage induced lysis in P. aeruginosa (10). There are 
seven phages associated with E. faecalis V583 with one of them being a part of the core 
genome (37). It will be interesting to test the role of σ54 dependent transcription of phage 
particle proteins and host lysis and its contribution to biofilm development. 
Enhancement of biofilm formation in the absence of a well characterized matrix 
component in the rpoN mutant indicates that a substantial knowledge gap still exists to 
unravel factors associated with E. faecalis biofilm development.  Cellular processes 
regulated by σ54 will be attractive in this regard to begin revealing the interplay between 
metabolism and biofilm development, as one of the few characterized roles for σ54 is the 
regulation of four sugar PTS pathways. It is noteworthy that deletion of the genes 
encoding the four known enhancer binding proteins (LpoR, MphR, MpoR, and MptR) 
did not reduce eDNA release, impair autolysis or alter biofilm development (data not 
shown), suggesting that σ54 might act as a repressor of genes independent of enhancer 
protein function.  The idea that σ54 levels in the cell or within the population might be 
regulated raises an interesting experimental question.  Our observation that the wild-type 
and rpoN complement strain could grow on 2DG at a much lower frequency (10
-4
 and 10
-
5
) relative to the rpoN mutant parallels a recent report by Flanagan et al. (18) in which 
resistance to the E. faecalis plasmid encoded bacteriocin MC4-1 (a class IIa bacteriocin) 
was dependent on point mutations within the rpoN gene that occurred at high frequency 
(10
-3
 to 10
-4
).  This resistance was shown to be reversible to a susceptible phenotype by 
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point mutations that also occurred within rpoN as second-site suppressors.  These 
combined observations suggest that there are hot spots for mutation within rpoN, and 
could be a mechanism for phase variation within the E. faecalis population.   
In Vibrio vulnificus, σ54 positively regulates the gene encoding an ADP-glycero-
manno-heptose-6-epimerase (gmhD) which is responsible for production of 
lipopolysaccharide and exopolysaccharide, both of which are required for biofilm 
formation (31) while in Burkholderia cenocepacia, σ54 controls motility which in turn 
plays a role in  biofilm formation (51). However, in E. coli K12, rpoN deletion enhances 
biofilm formation (3). Such different effects of rpoN on biofilm forming potential of 
bacteria provides a clear example of how  a gene whose function was first reported to be 
restricted to nitrogen assimilation has evolved to govern virulence related functions in 
addition to bacterial metabolism. Our data provide additional support for the expanding 
role of σ54 in the world of low-GC Gram-positive bacteria.   
Biofilm formation is a multistep process that begins with the attachment of 
bacteria to the substrate followed by colonization via further recruitment of more bacteria 
or by cell division. Initial attachment of a bacterial cell to a surface is an important stage 
in biofilm development and determines the fate of this process. In P. aeruginosa (8, 35), 
Staphylococcus aureus (11) and Streptococci (40) it has been shown that defect in initial 
adherence of the bacteria affect biofilm formation and subsequently influences the 
virulence of these pathogens.  Our data indicates a similar influence of attachment 
process in enterococcal biofilm development wherein deletion of rpoN increases the 
adherence potential of the pathogen which subsequently results in a more dense biofilm.  
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Other than DNA, other molecules such as proteins and polysaccharides have been 
suggested to be important constituents in the polymer matrix of several bacteria (16, 19).  
Robust biofilm in VI01 despite the significant reduction in eDNA led us to test for the 
presence of other matrix components using compounds capable of dissolving the 
aforementioned components.  The reduced ability of  VI01 (ΔrpoN) to form a biofilm 
when treated with proteinase K suggests a role for protein in either adhesion or matrix 
composition to promote E. faecalis biofilm and is consistent with recent observations by 
Guiton et al. (20).  These authors observed that colonization of an implanted piece of 
urinary catheter as well as the bladder epithelium was dependent on a functioning sortase 
enzyme for the proper anchoring of proteins to the cell wall, which in turn promotes 
cellular adhesion.  In S. aureus, a biofilm defect in mutants that over produce 
extracellular protease was rectified by the addition of  α2 macroglobulin – a general 
protease inhibitor, indicating  a vital role for proteins in either cellular adhesion or 
biofilm matrix (4) . Similarly in B. subtilis, TasA is required for the structural integrity 
and development of biofilms (7). In E. faecalis biofilms (54), eDNA is known to be a 
crucial matrix component in the early stages of biofilm development, but by 24 hours 
growth in the biofilm DNase has a minimal affect at disrupting the biofilm.  Here we 
show that in E. faecalis V583, proteins are likely to serve as important matrix 
components during the later stages of biofilm development as a reduction in biomass was 
observed following only at 24 hours and not at earlier timepoints.  This suggests the time 
dependent involvement of different polymers in the overall development of the biofilm.  
Complementation studies of the rpoN mutant using a low copy plasmid did not 
result in complete reversal of the phenotype to wild type levels in experiments that 
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involved stressing of cells (osmotic shock and 2DG toxicity)(data not shown).  This was 
primarily due to plasmid loss in the absence of selectioin, and suggested a survival 
advantage for E. faecalis in the absence of σ54 under certain stress conditions.  The 
inability to fully complement an rpoN mutant has also been reported in L. monocytogenes 
(42).  Similarly, in a V. fischeri squid colonization model (58), the level of colonization 
varied with the complemented strain and only some animals exhibited wild type levels of 
colonization.  For this reason, we utilized a complementation strategy that restored the 
function of the gene by placing it at its native locus in single copy.     
A literature survey for σ54 and its biological roles revealed a bias towards Gram- 
negative species with P. aeruginosa, Vibrio spps and E. coli being the most studied. In an 
attempt to identify the distribution of rpoN in low-GC Gram-positive organisms, we 
performed a BLAST search using σ54 of E. faecalis V583 as the query. Amongst the 
organisms queried, only L. monocytogenes, B. subtilis, C. difficle and C. perfringens 
appeared to have homologues, whereas in S. aureus, S. pneumoniae, and S. pyogenes 
homologs to σ54 were absent.  The basis for this distribution among enteric adapted 
organisms as well as the potential genes regulated by σ54 awaits further study. 
In conclusion, the results from this study show that σ54 in E. faecalis V583 
contributes to cell death and eDNA release, and that in its absence, E. faecalis adapts an 
alternate matrix to establish biofilms.  Understanding the mechanism underlying the 
phenotypes observed in this study is the main focus of ongoing studies in our laboratory. 
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Chapter 3 -  Influence of the alternate sigma 
factor RpoN on global gene expression and carbon 
catabolite repression in Enterococcus faecalis 
V583. 
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3.1 Abstract 
In this study, we show that the Enterococcus faecalis alternate sigma factor σ54 
(RpoN) and its cognate enhancer binding protein MptR are essential for mannose 
utilization and contribute to glucose uptake through the Mpt phosphotransferase system.  
To gain further insight into the E. faecalis RpoN-dependent genes, we performed 
microarray transcriptional analysis of strain V583 and an isogenic  rpoN mutant grown in 
a chemically defined medium with glucose as the sole carbon source.  In comparison to 
V583, 340 genes were differentially regulated in the rpoN mutant, and the majority of 
genes encoding known functions related to nutrient acquisition.  A comparative analysis 
of the transcription profiles of the rpoN mutant and a previously characterized mptD 
mutant (a gene known to be RpoN dependent) revealed significant overlap in the 
differentially expressed genes, including genes with predicted cre sites, consistent with 
loss of repression by the major carbon catabolite repressor, CcpA.  To determine if the 
inability to efficiently metabolize glucose/mannose as a carbon source affected infection 
outcome we utilized two distinct infection models, namely the rabbit endocarditis model 
and the murine model of catheter associated urinary tract infection (CAUTI).  Here we 
show that the rpoN mutant is significantly attenuated in both infection models.  We also 
identified a link with carbon catabolite control by examining a ccpA mutant in the 
CAUTI model.  This analysis showed that the absence of carbon catabolite repression 
significantly attenuates bacterial tissue burden.  Our data emphasize that proper 
regulation of central carbon metabolism contributes to in vivo growth of E. faecalis..  
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3.2 Introduction 
Enterococci have recently emerged as one of the leading causes of biofilm 
associated infections, including endocarditis and catheter associated urinary tract 
infections (CAUTI) (1). Infective endocarditis (IE) in simple terms is the infection of 
damaged heart valves. Three Gram-positive genera (Streptococcus, Staphylococcus and 
Enterococcus) represent 80% of the total reported cases of IE.  Enterococci account for 5-
18% of the cases or approximately 3000 cases per year in the United States (2). Among 
enterococcal species, E. faecalis causes 80% of the reported endocarditis cases (3). The 
increasing emergence of antibiotic resistance in Enterococcus is of heightened concern 
while treating patients with IE due to the potential of recurrent infections with resistant 
species. Healthy endothelium is generally considered resistant to bacterial infection. 
Endothelial damage is brought about by a variety of conditions such as rapid blood flow 
associated with congenital heart disease, inflammation due to rheumatic carditis, 
degenerative valve lesions in the elderly or due to catheterization (4).  Fibrin and platelets 
are deposited on the damaged endocardium and serve as an ideal focal point for bacterial 
adherence (5) resulting in bacterial colonization on the heart valves.  These vegetations 
have the potential to embolize, disseminate and infect other organs leading to the onset of 
a systemic infection.  
In recent decades, a growing number of enterococcal virulence factors have been 
identified that contribute to endocarditis, including aggregation substance (6, 7), pili (8, 
9) and two metalloproteases, the extracellular gelatinase and the membrane protease Eep 
(10-12).   
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Like endocarditis, CAUTI is also thought to be a biofilm-mediated disease and 
enterococci now rank as the second leading cause of CAUTI in U.S. hospitals (1).  A 
growing number of virulence factors are associated with enterococcal CAUTI, including 
the membrane protease Eep and the transcriptional regulator AhrC (13) as well as the 
chromosomally encoded pili and associated sortases (14-16).  Not surprisingly, these 
aforementioned virulence factors also contribute to in vitro biofilm formation by E. 
faecalis (12, 13, 16).   
A large gap in our knowledge base pertains to how organisms, including E. 
faecalis, survive in nutrient poor environments, as would be expected to occur within a 
host.  While several studies have examined the transcriptional profile of cells grown in 
urine and serum to approximate the in vivo condition (17, 18), our understanding of 
preferred nutrients and how E. faecalis acquires them in the host is in its infancy.     
Because carbon acquisition and its regulation have received much attention in the 
last decade and are now being proven to be key drivers to in vivo fitness in a growing 
number of bacterial pathogens(19-25), we addressed the question of whether altered 
carbon utilization might affect the ability of E. faecalis to grow in vivo using two biofilm 
mediated infection models (lupine endocarditis and murine CAUTI).  The choice of these 
two models was based on the differences in nutrient availability at these two sites.  We 
recently showed that the alternate sigma factor σ54 (RpoN) contributes to in vitro biofilm 
formation in E. faecalis as an rpoN deletion mutant was shown to have an altered biofilm 
matrix composition (26).  The rpoN mutant was less efficient at autolysis (less eDNA in 
the matrix) and the biofilm became more labile to protease K treatment compared with 
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the parental strain.  In addition, σ54 (RpoN) is also known to regulate several 
phosphotransferase systems (PTS) including the mannose/glucose permease Mpt (27) 
making it a good candidate to explore its contribution to in vivo fitness.   
In contrast to other sigma factors, σ54 is unable to initiate open complex 
formation upon association with target DNA and the core RNA polymerase and requires 
the assistance of an enhancer binding protein (EBP).  EBPs are ATPases that act as 
mechano-transcriptional activators to facilitate the transition of  the inactive RpoN-RNA 
polymerase closed complex to active open complex essential for transcription initiation 
(28).  In E. faecalis, four EBPs are encoded on the V583 genome (MptR, MpoR, MphR, 
LpoR) with a 5th (XpoR) disrupted by an insertion element (27). The genes encoding 
each of these EBPs are positioned immediately upstream of their respective sugar PTS 
genes (27).   
The best characterized PTS in E. faecalis is the aforementioned Mpt 
mannose/glucose permease (27, 29, 30), owing to the fact that components of this PTS 
complex are known cellular receptors for class IIa and IIc bacteriocins (31).  The Mpt 
PTS complex is comprised of four proteins, Mpt A-D.  Like other characterized PTS 
systems (32), MptC and MptD are positioned as integral membrane proteins where they 
are thought to bind and channel the sugar inside the cell.  Upon entry, the sugar is 
phosphorylated by MptB (EIIB), which is in turn phosphorylated by MptA (EIIA) in the 
protein complex.  As an EIIA enzyme, MptA is thought to be phosphorylated by Hpr, 
which gains the phosphate from enzyme EI after phosphorylation of EI by phosphoenol 
pyruvate (PEP).    
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Recent work by Opsata et al. (30) characterized the transcriptional profile of a 
mutant of mptD that conferred resistance to pediocin PA-1, a known class IIa bacteriocin.  
These authors identified a number of differentially expressed genes in the mptD mutant 
that contained putative catabolite responsive elements (cre) sites 
(WTGNAANCGNWNNCW) based on similarity to consensus cre sites from Bacillus 
subtilis (33).  In low G-C Gram-positive bacteria, cre sites on DNA are bound by a 
protein complex consisting of the carbon catabolite repressor CcpA and the 
phosphorylated Ser-46 form of Hpr (34).  Cre sites are generally positioned within or 
immediately downstream of the target gene promoter where the bound CcpA-Hpr 
complex blocks transcriptional procession of the target gene.        
Because σ54 has been shown to regulate the expression of various genes involved 
in metabolism and virulence in other bacteria (35-39), we performed a microarray 
transcriptional analysis to identify genes whose expression was differentially regulated in 
the E. faecalis rpoN mutant.  This dataset allowed a comparative analysis with the mptD 
mutant profile reported by Opsata et al. (30); as σ54 is known to directly regulate the 
expression of the mpt operon.  We also show that the absence of σ54 results in 
derepression of CcpA controlled genes in E. faecalis.   We similarly observed that genes 
with cre sites that overlapped the promoter or were positioned downstream of the 
promoter region were up-regulated in the rpoN mutant.   
Furthermore, as the array data indicated an increased expression level of 
catabolite repressed genes, we also evaluated a ccpA mutant in a murine model of 
CAUTI.  To our knowledge, this report represents the first examination of the 
contribution of either σ54 (RpoN) or CcpA to in vivo fitness in E. faecalis.     
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Overall, this study provides important evidence linking basic metabolism with in 
vivo growth, and provides the rationale for several distinct pathways that could be 
targeted as a potential therapeutic for treating enterococcal infections. 
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3.3 Materials and Methods 
Bacterial Strains and growth conditions: 
Bacterial strains used in this study are listed in Table 3-1. For propagation of 
plasmids, Escherichia coli ElectroTen-Blue from Stratagene was cultivated in Luria-
Bertani (LB) broth supplemented with appropriate antibiotics whenever necessary. 
Unless otherwise mentioned, E. faecalis was cultured in Todd-Hewitt broth (THB; BD 
Biosciences) containing appropriate antibiotics. For antibiotic selection, chloramphenicol 
(Cm) at a concentration of 10µg/ml and 15µg/ml was used for E.coli and E. faecalis 
respectively. 
Table 3-1 Enterococcus faecalis strains used in this study. 
Strain Genotype or Description Reference 
V583 Parental strain Clinical isolate (70) 
VI01 V583ΔrpoN (26) 
VI40 VI01::rpoN (26) 
MG07 V583ΔmptR This study 
MG08 V583ΔlpoR This study 
MG09 V583ΔmpoR This study 
MG10 V583ΔmphR This study 
EH01 V583∆ccpA This study 
VI70 EH01∆ef0114 This study 
AH05 EH01Δef0362-61 This study 
AH10 EH01Δef2863 This study 
IH12 EH01∆ef2863∆ef0362-61 This study 
In-frame markerless deletion of activator proteins: 
Using the temperature sensitive cloning vector, pLT06 (65), isogenenic in-frame 
deletion mutants of the four activator proteins were generated in E.faecalis V583. 
Upstream and downstream flaking regions of the targeted activator proteins were 
amplified using primers listed in Table 3-2. The primer pairs MptRP1/MptRP2 and 
MptRP3/MptRP4 were used to amplify flanking regions upstream and downstream of 
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mptR respectively. To facilitate cloning, primers MptRP1/ MptRP2 were designed with 
EcoRI/BamHI restriction sites respectively whereas MptRP3/MptRP4 were designed 
with BamHI/PstI sites respectively. For the construction of the insert, the amplified 
regions were digested with BamHI, ligated and re-amplified with MptRP1 and MptRP4. 
To generate pMG07 (mptR deletion vector), the amplified insert fragment was digested 
and ligated with EcoRI/PstI cut pLT06 cloning vector.  The ligated vector and insert was 
electroporated into E. coli ElectroTen - Blue and correct constructs were identified by 
colony PCR. The construct was screened by restriction digest analysis and then 
electroporated into competent E. faecalis V583 cells. MG07 [V583ΔmptR] was 
subsequently generated as previously described (66) and confirmed by PCR using the 
primers MptR-Up and MptR-Down. A similar approach was used to create all the 
mutants used in this study (Table 3-1). 
Growth Assessment in Nutrient limiting conditions: 
Using a single colony of each strain, liquid cultures were started in THB. 
Bacterial cultures were grown at 37°C overnight.  For growth  analysis, overnight 
cultures were diluted 1:100 in complete defined medium (CDM) (40, 41) supplemented 
with a range of either glucose, mannose or N-acetyl glucosamine concentrations (10mM, 
50mM, 100mM and 200mM). Growth was monitored for 12 hours in an Infinite M200 
Pro plate reader (Tecan Trading AG, Switzerland) at 37°C with orbital shaking at 250 
rpm. The experiment was performed with 5 internal replicates and repeated twice.  
Microarray analysis: 
Colony biofilms (67) were grown similar to those reported previously (68). 
Briefly, E. faecalis strains were grown overnight in 2mL of CDM cultures with 100 mM 
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glucose and 20μM hematin added, shaking at 150 rpm at 37°C. Overnight cultures were 
sub-cultured 1:1000 in the same growth conditions and allowed to grow to  an OD of 
approximately 0.2  then diluted in fresh medium to an A600 of 0.1 (approximately 10
8 
cells/mL). 10μL of this solution was added in three discrete spots to a 25 mm, 0.2 μm 
pore polycarbonate membrane affixed to the surface of CDM+1% agarose solid medium 
in a 100mm Petri dish. Plates were incubated ~16 hours at 37°C and polycarbonate 
membranes were moved to unoccupied areas of the dish and further incubated at 37°C for 
an additional 4 hours. Membranes were then transferred to 1.5mL microcentrifuge tubes 
containing 1mL of RNALater (Ambion) and vortexed until no visible cells remained 
attached to the membrane surface. Cells were pelleted by centrifugation (2 mins at 
10,000xg), supernatants removed and cell pellets stored for RNA purification. RNA 
purification and Affymetrix microarray preparations were performed as described 
elsewhere (68, 69). 
Array analyses were performed using RMA analysis through the University of 
Oklahoma Bioinformatics Core Facility (http://www.ou.edu/microarray/). 2Sigma 
analysis was used to determine the significant difference of fold change with a 95% 
confidence interval. Significant fold changes were considered for values greater than 3 
fold for the rpoN mutant vs. wild-type and greater than 1.8 fold for the complement vs. 
wild-type comparisons.  
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Table 3-2 Oligonucleotides used in this study, 
Primer Sequence (5'-3') 
LpoRP1 GAGAGAATTCGATTGACAAGTTAAAAAAACG 
LpoRP2 CTCTGGATCCCTTCCGAGATTTCATGGAATC 
LpoRP3 GAGAGGATCCGAAGCGGAAGTTGCGCAT 
LpoRP4 CTCTCTGCAGGATAGCCAATGTACCATTCC 
LpoR-Up ATGCAAATTGCTGAAGTTGCT 
LpoR-Down GCTAGCTCATTCACATTGTAT 
MphRP1 GAGAGGATCCGCTTCAATATCATCAATCGTTTA 
MphRP2 CTCTTCTAGATAACATAAAATCACCTCTCGC 
MphRP3 GAGATCTAGAACGGAGTTTAACAACGCAGA 
MphRP4 CTCTCCATGGATGCAACCTAAAAGAATCGCT 
MphRUp GTGATGAAGTGAAATGCTTTC 
MphRDown CTTGAAAGCAACGAGGTTCC 
MpoRP1 GAGAGGATCCGAGCACATTCGTCAACGAATG 
MpoRP2 CTCTCTGCAGGTGAAACTGTTTTAACGCTTGATG 
MpoRP3 GAGACTGCAGAAGGCTTAATTCAAACGGAAATG 
MpoRP4 GCTGAGACAGCATGCCTGAA 
MpoRUp GCAGCAGTAACGATGGAAGA 
MpoRDown GTGGAGGTGACTCCGAGATA 
MptRP1 GAGAGAATTCATTTTGTCGCTAGTTGGCTTG 
MptRP2 CTCTGGATCCAATCCGCTCATTTTTGATGG 
MptRP3 GAGAGGATCCACCGAAATTGATACACTAGAT 
MptRP4 CTCTCTGCAGAAAGATCATTGCACCAGATTG 
MptRUp CGAGAGGAAGGCTTGAATGTC 
MptRDown CGATGCAATGGCTTCTTGCA 
CcpAP1 GAGAGAATTCCAGAAGGTTCCAAGTAGCTG 
CcpAP2 CTCTGGATCCATTTGCCTCTCTAGCAACATC 
CcpAP3 GAGAGGATCCACAGTTGTTTTACCTTATGGAATTG 
CcpAP4 CTCTCTGCAGGACTTATGCTGATGGTCGTG 
CcpA-Up GCTGTAACACCAGGTTTCAC 
CcpA-Down GATCGTCAAGTTGGTTCTACG 
EF0114P1 GAGAGAATTCCGTGAAGTTACACTGAACAAG 
EF0114P2 GAGAGGATCCTTTCTGCACTCCGTTCAT 
EF0114P3 GAGAGGATCCCGCTAATGGATACGTTCTCG 
EF0114P4 CTCTCTGCAGCTTGATTGACAGCTTCCAGC 
EF0114-Up GATGGGAAGCCAGTAATAAGAG 
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EF0114-Down CGTGCTGGCATATAATTGACC 
EF0362-61P1 GAGAGAATTCGATGGATAGTATCTTTCATGCC 
EF0362-61P2 CTCTGGATCCAACAAAACTAAAAGCCAGGACG 
EF0362-61P3 GAGAGGATCCGCGACACGTTATAGTAACCTTG 
EF0362-61P4 CTCTCTGCAGCGACTAAAGTGTTAATGAACAG 
EF0362-61 Up GCGATATTACGAGATACATG 
EF0362-61 
Down 
TGAAGTCATGGCAGTGACGT 
EF2863P1 GAGAGAATTCTCGATACGTTGGCCATCTTC 
EF2863P2 CTCTGGATCCGGTCTTGCGAAGGACGCTC 
EF2863P3 GAGAGGATCCCGAACTATTCACCAACTGTTC 
EF2863P4 CTCTCTGCAGATCCTCTAAAGTTGAAGAGACG 
EF2863-Up CTGATCCGGAACTGTTACTG 
EF2863-Down TATCATTAACTGCTTGTCGG 
EF0019f ATTGGCGGAATGAGTTTCAG 
EF0019r GCTGGCGTTATTTTCTTTGC 
EF0082f TGTCAAAGGTGAACGCTACG 
EF0082r TGAGGACTTGGGCTTTCTTG 
EF2223f AACATCGGCGGTATCTTCAG 
EF2223r TGGTTCAATTCGACGAACAA 
EF0891f TGTCACAGCAAGCAGGAATC 
EF0891r TTCCACAAAAGGAACGGAAG 
EF0013f TTGGATGATGCAGAACGAAG 
EF0013r CTTGCAAGCCAGCAGTCAT 
 
Table 3-3 Plasmids used in this study 
  
Quantitative real time (q-RT) PCR:  
Synthesis of cDNA was performed using Superscript II reverse transcriptase 
(Invitrogen) from RNA templates utilized in the above transcriptome studies following 
Plasmid Description Reference 
pLT06  Parent Deletion vector; chloramphenicol resistance  (19) 
pMG07  pLT06 + engineered mptR deletion This study 
pMG08 pLT06 + engineered  lpoR deletion  This study 
pMG09 pLT06 + engineered mpoR deletion  This study 
pMG10 pLT06 + engineered mphR deletion  This study 
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the manufacturer’s instructions. Random hexamer primers (Qiagen) were used in the 
initial synthesis reaction. The primers used in q-RT PCR analysis are listed in Table 3-2. 
The q-RT PCR reaction was performed with 100 ng of cDNA and 300 nM of each primer 
using Quanta SyBr Green fast mix (VWR) on a Biorad MJ MiniOption Real time PCR 
system. Following denaturation at 95°C for three minutes, the q-RT PCR reaction was set 
for 50 cycles with 95°C for 10 seconds, 60°C for 20 seconds and 72°C for 10 seconds. 
Differential gene expression was calculated using the ΔΔCt method using the threshold 
cycle values for the gene of interest (ef0019, ef0082. ef2223, ef0891) and the endogenous 
control [ef0013(dnaB)]. 
RNAse B Assay 
The glycosyl hydrolase activity was determined using the high mannose 
containing glycoprotein RNAse B (New England Biolabs) as the substrate. The bacteria 
were grown overnight at 37°C in CDM containing 20mM glucose and 20μM heme, 
shaking at 250rpm. To assess the glycosyl hydrolase activity , 5μg of RNAse B was 
incubated with the filtered supernatants in 1X G7 Reaction buffer (New England Biolabs)  
at 37°C overnight. EndoH (New England Biolabs) used as a positive control. The 
samples were separated on 15% SDS-PAGE followed by staining with Coomassie blue. 
Chitinase Assay 
The fluorogenic glycanase substrate 4-methylumbelliferyl b-N, N’, N’’-
triacetylchitotrioside (Sigma) was used to test for chitinase activity in the filtered 
supernatants of the bacterial cultures grown overnight in CDM containing 20mM glucose 
and 20μM heme. Briefly, 50μl of the filtered supernatant was incubated with 50μM 
substrate in 25mM citrate buffer (pH 6) for 15 minutes. The fluorescence intensity 
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(excitation 360 nm, emission 450 nm) was measured in an Infinite M200 Pro plate reader 
(Tecan Trading AG, Switzerland). Chitinase activity is expressed as relative fluorescence 
calculated by dividing the fluorescence emitted at 450 nm by the OD 600nm of the 
culture. 
Animal Models 
All the procedures in the rabbit model to study experimental endocarditis and 
murine model for catheter associated urinary tract infection were performed in 
compliance with Animal Welfare Act and other federal statutes and regulations relating 
to animals and experiments involving animals. 
Experimental Endocarditis and determination of bacterial burden 
Left sided endocarditis was induced in New Zealand white rabbits (Charles River 
Laboratories International, Inc.) by introducing a polyethylene catheter with an internal 
diameter of 0.86 mm (Becton Dickinson, MD) followed by injection of bacterial cultures 
(10
7
 CFU ; E.faecalis V583(70) and VI01(26)) via marginal ear vein after 24 hours of 
catheterization as previously described (10). In preparation for injections, bacterial 
cultures grown to stationary phase were washed twice and diluted to achieve a 
concentration of 10
7
 CFU/ml in sterile saline. Group of eight rabbits were injected with 
each bacterial strain (V583 and VI01) and two negative controls were injected with 
sterile saline. The  rabbits were monitored for 48 hrs after bacterial inoculation and 
euthanized by intraperitoneal administration of sodium pentobarbital. Immediately after 
euthanasia, a cardiac stick was performed to determine bacterial CFU in blood at the time 
of sacrifice. Bacterial burden in the heart, liver, spleen and kidney was assessed by plate 
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count following previously described protocol (10) and expressed as log10 CFU/gm of 
tissue 
Murine model for Catheter Associated Urinary Tract infection (CAUTI) 
Catheter associated urinary tract infections using six-seven week old female wild-
type C57BL/6 mice. The mice were anesthetized by isoflurane inhalation and a 5-6 mm 
platinum cured silicone implant tubing (Renasil Sil025; Braintree Inc) was transurethrally 
placed in the urinary bladder of the mice as previously described (14). Post implantation, 
the mice were injected with 50 μl inocula of either sterile PBS or bacterial suspension (~ 
2x10
7
 CFU) by transurethral catheterization. The mice were monitored for 48 hours post 
implantation and infection. They were euthanized by cervical dislocation after inhalation 
of isoflurane. To determine the degree of infection, kidneys and bladder were harvested 
aseptically and their bacterial burden was determined. Also, the silicone implant tubing 
was retrieved from the bladder and the bacterial burden enumerated using THB media. 
Bioinformatics and Statistical Analysis: 
Cre (Catabolite responsive elements) sites were identified upstream of the 
differentially expressed genes using the pattern analysis option in Regulatory Sequence 
Analysis Tools (http://rsat.ulb.ac.be/rsat/). 
The statistical analysis of the chitinase assay and bacterial burden determined in 
the various organs in the endocarditis study and CAUTI was performed using GraphPad 
Prism 5 software (San Diego, CA).  
 Statistical significance was measured using a non-parametric T-test (Mann-Whitney 
Test). 
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3.4 Results 
RpoN and MptR regulate glucose uptake and are required for mannose 
uptake:  
We have previously demonstrated that deletion of rpoN has no growth defect in 
an enriched medium such as tryptic soy broth (26) or Todd-Hewitt broth.  However, 
several sugar uptake systems in E.faecalis are known to be regulated by RpoN (27). 
Therefore we hypothesized that in a chemically defined media with specific 
carbohydrates as the major carbon nutrient source, RpoN might be indispensable for the 
bacteria.  To this end, we assessed the fitness of the mutant in a chemically defined 
medium (CDM) (40, 41) with varying concentrations of sugars. Figure 3-1 shows the 
growth pattern in CDM with glucose as the sole carbon source.  As evident from the 
growth curves, the mutants (rpoN and mptR) grew poorly in glucose concentrations at 10 
mM and 50 mM glucose.  At 100 mM glucose, the wild-type and mutants grew at similar 
rates into the early exponential phase and then the mutants grew more slowly than the 
wild-type, presumably as glucose levels were depleted below an optimal growth 
threshold for the mutants.  In higher concentrations of glucose (200 mM) the mutants did 
not achieve maximal growth as compared to the parental strain, but were capable of 
sustaining growth equivalent to the parent through the mid-exponential phase, again 
likely attributed to a threshold glucose concentration being exhausted followed by growth 
delay in the mutant.   
Strikingly, the growth defect of the mutants in CDM + mannose was not 
compensated by supplementation with increasing concentration of mannose as was 
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observed with glucose (Figure 3-2), suggesting that the Mpt PTS controlled by σ54 and 
MptR represents the sole mannose transporter in the cell.  To ascertain the sugar 
specificity of the PTS controlled by MptR and σ54, we grew cells in CDM + N-
acetylgucosamine (NAG) as a sugar source. It is clear from Figure 3-3 that the absence of 
either σ54 or MptR does not impede the growth on N-acetylglucosamine as the major 
carbon source.  In addition to NAG, galactose was also tested and no observed 
differences were noted between the growth pattern of the mutants and the wild type (data 
not shown).  Together the growth curve analysis confirms that RpoN and MptR regulate 
the glucose/mannose specific permease.      
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Figure 3-1 Growth of E.faecalis in chemically defined medium with glucose as the 
carbohydrate source. 
The glucose concentrations are indicated below each panel. Each graph is the average of 
the replicates with the standard error of the mean show. The growth curves are shown in 
black (V583), blue (VI01 [ΔrpoN], and green [ΔmptR]. 
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The concentration of mannose is indicated below each panel. Each graph is the average 
of ten replicates wirh the standard error of the mean shown. The growth curves are shown 
in black (V583), blue (VI01 [ΔrpoN]) and green (MG07 [ΔmptR]). 
 
 
 
 
 
 
Figure 3-2 Growth of E.faecalis in chemically defined medium with mannose as the 
principle carbon source.  
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The concentration of N-acetlyglucoamine is indicated below each panel. Each graph is 
the average of ten replicates with the standard error of mean shown. The growth curves 
are shown in black (V583), blue (VI01 [Δ rpoN] and green (MG07 [ΔmptR]). 
 
 
 
 
 
 
 
 
Figure 3-3 Growth of E.faecalis in chemically defined medium with N-
acetylglucosamine as the sole carbon source. 
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Transcriptional Analysis of E. faecalis V583 ΔrpoN (VI01): 
RpoN is known to impact the global gene expression profile in several bacteria 
and the genes it regulates are functionally divergent (38, 42, 43), indicative of functional 
divergence between the Gram-negative and Gram-positive bacteria under study.  In 
E.faecalis, the only genes that have been described to be regulated by RpoN are the four 
putative PTS related operons (27). On the basis of the phenotypes we observed in our 
previously published work (26) and the present effect of RpoN on growth in glucose and 
mannose, we hypothesized that in E.faecalis, RpoN would have an impact on a larger 
regulatory gene network. Therefore, using DNA microarrays of E. faecalis strain V583, 
the transcriptional profile of VI01(ΔrpoN) was compared to that of the parental strain 
V583 and an rpoN  complemented strain (VI40) grown on polycarbonate filter discs 
placed on 1% agar growth medium containing CDM + 100 mM glucose.  The filters were 
passed twice over a 20 hour period to fresh sections of the agar medium to allow 
transcriptional analysis in the early exponential phase of growth, before glucose became 
exhausted below a level that would sustain adequate growth of the mutant.  The overall 
cellular yield of all strains grown under these conditions was similar.  The microarray 
data were taken from two biologic replicates and differentially expressed genes were 
identified by RMA analysis. The raw array data has been deposited in the NCBI Gene 
Expression Omnibus (http//:www.ncbi.nlm.nih.gov/projects/geo/) under accession 
number GSE40237.   
Compared to the parental strain and the rpoN complemented strain, the rpoN 
mutant displayed 340 genes that were differentially regulated (Figure 3-4, SI Table 1) out 
of which 34% are hypothetical genes or proteins with no known functions, 17% are genes 
related to transport and binding proteins, 14% are energy metabolism related and 12% are 
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genes that encode PTS proteins.  Of the 340 differentially expressed genes in VI01, 255 
genes were upregulated and 85 genes were downregulated (≥ 3-fold) compared to the 
parental and complemented strain.  Of the four PTS systems known to be regulated by 
RpoN, two were significantly downregulated (mpt and lpo; average 134 fold and 4 fold 
respectively) and no significant difference in expression was observed in the mpo and 
mph PTS systems. 
Quantitative real time PCR confirmation of the microarray data 
To validate the microarray data, we performed qRT-PCR on a set of genes that 
represented both up (ef0891 and ef2223) and down regulated (ef0019 and ef0083) genes 
in an rpoN mutant.  This list of validated genes included those whose expression profile 
was found be in common with the mptR/mptD transcriptome (ef0019 and ef2223) (30) as 
well as those genes that were unique to rpoN (ef0082 and ef0891).  We confirmed the 
reduced expression of ef0019 (mptB) and ef0082 in an rpoN mutant and also showed that 
ef0891 and ef2223 were significantly upregulated in the mutant background relative to 
the parental strain V583 consistent with the levels of gene expression observed in the 
microarray (Table 3-4) 
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The number in each functional category is the percentage of the differentially expressed 
genes. 
 
 
 
Figure 3-4 Pie chart depicting the functional distribution of 340 differentially 
expressed genes in VI01 in comparison to the wildtype V583.   
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Table 3-4 Microarray expression profile validated with quantitative Real time PCR 
Catabolite repression elements (cre) in RpoN-dependent genes. 
In order to gain additional insights into the genes regulated by RpoN which might 
be independent of its influence on Mpt, we compared the transcription profiles of the 
rpoN mutant with the published data for an mptD mutant (30).  Both studies were 
performed with mutants in the V583 lineage, thus eliminating strain background biases.  
Other aspects of the experimental conditions were more variable (M17-Glucose vs. 
CDM-Glucose).  Despite these varied growth conditions, we felt that this comparison 
would provide a rough estimate of those genes that might be unique to RpoN, and 
independent of the Mpt system. 58.9% of the genes that were differentially regulated in 
the mptD mutant were also found to be significantly altered in gene expression in the 
rpoN mutant but that represented only 31.2% of the differentially expressed genes in 
rpoN mutant. It was surprising to note that 42.1% of genes in the mptD mutant appeared 
to be independent of RpoN as the mpt operon is regulated by RpoN (Figure 3-5). This 
again could be attributed to the different experimental growth conditions used in the two 
studies.   
The increased expression levels of genes encoding several sugar uptake systems 
as well as ABC transporters in the transcription profile of the rpoN mutant suggested a 
Gene Function 
Fold change 
Microarray 
Analysis 
Quantitative Real 
time PCR 
EF0082 Major facilitator family transporter -6.82 -8.64 
EF0019 EIIB component of mpt operon -152.11 -190.90 
EF0891 Aspartate aminotransferase, putative 47.93 140.86 
EF2223 ABC transporter, permease protein 257.25 1175.42 
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loss of catabolite control.  In order to determine the presence of such regulation, we 
searched the regions upstream of the differentially regulated genes in the rpoN mutant to 
identify cre sites.  Cre sites have also been reported for genes whose expression was up 
regulated in an mptD mutant (30), most of these were also found to be upregulated in 
VI01 (Supplemental Table 3-2). We used the cre consensus sequence suggested for E. 
faecalis  5`-WTGWAARCGYWWWCW-3`(30) as our pattern query using the 
Regulatory Sequence Analysis Tool (http://rsat.ulb.ac.be/) to identify cre sites upstream 
of the genes that were unique to the rpoN mutant but that were not shown to be 
differentially regulated in the mptD mutant (30).  Of the 154 rpoN mutant specific genes 
that were upregulated, cre sites were present in the promoter regions of 22 genes (14.28 
%) (Supplemental Table 3-5). Of the 80 downregulated genes, one gene (sdhB-2) had a 
predicted cre site in the region downstream of the predicted promoter. The identified cre 
sites matched the exact consensus (5’- WTGWAARCGYWWWCW-3’) or possessed a 
one base mismatch from the consensus sequence. 
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Figure 3-5 Venn diagram illustrating the overlap between differentially expressed 
genes in VI01 (ΔrpoN) and in the mptD insertion mutant in E. faecalis V583. 
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Carbon catabolite repression regulates glycozyl hydrolase activity. 
Three gene clusters (ef0114[ndoE], ef2863, and ef0362-61) encoding putative 
endoglycosyl hydrolases were highly upregulated in the rpoN mutant (SI Table 1) and 
putative cre sites were identified downstream of their promoter regions (SI tables 4 and 
5), indicating that these genes are under catabolite control.  In order to test the activity of 
their gene products, the three gene clusters encoding the predicted glycosyl hydrolases 
were deleted in the ccpA mutant background to eliminate the influence of catabolite 
repression on the expression of these glycosyl hydrolase genes. The glycosyl hydrolase 
activity present in the filtered supernatant of the various strains was tested for the ability 
to breakdown the high mannose containing glycoprotein RNAseB, as well as the chitin 
fluorogenic substrate 4-methylumbelliferyl b-N, N’, N’’-triacetylchitotrioside (4-MU-
chitotrioside).  EF0362-61 has been examined previously for chitinolytic activity based 
on homology to chitin-binding proteins (EF0362=ChiB) and chitinases (EF0361=ChiA) 
(44, 45).  Since the genes in the ef0362-61 operon were highly upregulated [84 and 69-
fold, respectively] in the ΔrpoN mutant and a cre site was found upstream of the ef0362 
gene, we hypothesized that deletion of the ef0362-61 operon would affect the chitinolytic 
activity in E.faecalis V583.  As evidenced in Figure 3-6, culture supernatant from V583 
possessed chitinolytic activity (~ 3900 rfu), but this activity was significantly increased ~ 
2-fold (~ 7800 rfu) in the ccpA mutant (EH01).  Surprisingly, AH05 [ΔccpAΔef0362-61] 
was not significantly different from EH01 [ΔccpA], suggesting that EF0362-61 does not 
contribute in a significant way to the breakdown of 4-MU-chitotrioside under these assay 
conditions.  Although the purified proteins EF03612-61 have been previously shown to 
exhibit chitinolytic activity (44, 45), our results demonstrate that the gene products of 
ef0362-61 contribute little activity to the overall breakdown of the fluorogenic chitin 
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substrate.  The absence of correlation with chitinolytic activity for EF0362-61 may be 
due in part to the fact that multiple glycosyl hydrolases are known to target 4-MU-
chitotrioside including lysozyme (46).   Further analysis showed that both EF0114 and 
EF2863 contribute to the chitinolytic activity, as deletion of either gene (VI70 [Δef0114] 
and AH10 [Δef2863]) resulted in a significant reduction in chitinolytic activity compared 
to the ccpA control.   
The gene products for EF0114 and EF2863 have previously been characterized as 
possessing activity that removes high mannose and hybrid-type N-linked glycans from 
glycoproteins, including RNAse B (47, 48) and human IgG (48).  To confirm these 
previous observations, we used the glycoprotein RNase B to assess glycolytic activity.  
The removal of the N-linked glycoconjugate (deglycosalation) reduces the apparent 
molecular weight of RNase B and results in a downward size shift on SDS-PAGE and 
this was confirmed with the EndoH control.  As the wild-type still produces some 
hydrolase activity, a mixture of glycosylated and deglycosylated forms of RNase B was 
observed (Figure 3-7).  However, only the deglycosylated form of RNase B was observed 
after treating with supernatant from strain EH01 (ΔccpA).  As shown in Figure 3-7, 
deletion of ef2863 in the ccpA mutant background (AH10) results in the elimination of 
nearly all of the lower deglycosylated form of RNase B, suggesting that EF2863 
contributes substantial glycosyl hydrolase activity towards this substrate, and is 
consistent with published observations (47).   
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Chitinase activity was determined using the fluorogenic substrate 4-methylumbelliferyl 
b-N, N’, N’’-triacetylchitotrioside and is expressed as relative fluorescence calculated by 
dividing the fluorescence emitted at 450 nm by the absorbance of the culture at OD 600 
nm. The statistical significance is calculated using Mann-Whitney test and is indicated as: 
β, p value less than 0.001 relative to V583; **, p<0.05 relative to ΔccpA.  The experiment 
was repeated 3-5 times and the error bars depict standard error of the mean. 
 
 
 
 
 
Figure 3-6 Chitinolytic activity detected in the culture supernatant of wild-type 
V583, EH01 [ΔccpA] and the endoglycosyl hydrolase mutants in the ΔccpA 
background: VI70 [ΔccpAΔef0114], AH10 [ΔccpAΔef2863] and AH05 
[ΔccpAΔef0362-61].   
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(A) RNAse B control; (B) RNase B treated with EndoH (New England Biolabs); (C-F) 
RNase B treated with supernatants from (C) V583; (D) EH01 [ΔccpA]; (E) VI70 
[ΔccpAΔef0114], (F) AH10 [ΔccpAΔef2863] and (G) AH05 [ΔccpAΔef0362-61].  
Deglycosylation of RNase B substrate results in increased mobility through an SDS-
PAGE resulting in a size shift.  The red arrow depicts the fully glycosylated form of 
RNase B, the blue arrow shows the fully deglycosylated form of RNase B, and the black 
arrow shows the location of the EndoH enzyme in the control treated lane. 
 
Role of RpoN in enterococcal virulence. 
We have previously shown that E.faecalis V583 ΔrpoN (VI01) exhibited 
resistance to autolysis and formed altered biofilm structures in which the matrix was 
more protease K labile (26). On the basis of these results and the fact that RpoN plays a 
key role in regulating the uptake of mannose and glucose, we hypothesized an important 
contribution of RpoN to the in vivo fitness of E. faecalis. To determine the role of 
enterococcal RpoN in virulence we used two models of infection: rabbit endocarditis (10) 
and a murine model of catheter associated urinary tract infection (14).  In the rabbit 
endocarditis model, the parental strain (V583) was compared to its isogenic rpoN mutant 
(VI01) for the ability to establish infective endocarditis, and mean bacterial burden on the 
valve, heart, liver, spleen and kidneys as well as in the blood was assessed.  As observed 
in figure 6, a significant reduction (p< 0.05) in the mean bacterial burden was noted in the 
Figure 3-7 Endoglycosidase activity against the RNase B substrate in the culture 
supernatants of V583, ΔccpA and the glycosyl hydrolase mutants in the ccpA 
mutant background.   
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vegetation, blood, spleen and kidneys of the rabbits infected with VI01 in comparison to 
the parental strain suggesting that rpoN contributes to infective endocarditis in rabbits 
(Figure 6).  The histopathological staining of VI01 infected heart valves also revealed 
fewer bacteria and increased heterophil influx in contrast to the parental V583 strain (data 
not shown) emphasizing the importance of a functional RpoN in establishing infection. 
Due to the cost associated with the rabbit model of endocarditis, the ccpA mutant was not 
included in the study.  We did, however, assess the contribution of both RpoN and CcpA 
in the murine model of CAUTI.  Similar to the observation in the endocarditis model, the 
rpoN mutant was significantly attenuated in CAUTI as observed by the reduced number 
of bacteria (p<0.05) recovered from the bladder and catheter of the rpoN infected mice 
compared to the wild-type strain V583 (Fig. 7).  In comparison to the wild-type and the 
rpoN mutant, the ccpA mutant was more highly attenuated for in vivo fitness as the mean 
bacterial numbers for the ccpA mutant isolated from the catheter were 15-fold lower than 
the rpoN mutant and 500-fold lower than the wild-type (p<0.005).  The mean bacterial 
burden in the bladder for the ccpA mutant was 90-fold lower than the wild-type and 13-
fold lower than the rpoN mutant (p<0.005). 
 
 
 
 
 
 
 
93 
 
 
 
 
 
Rabbits were euthanized post-infection and organs were harvested to enumerate bacterial 
burden. Bacterial burden for wild-type V583 (●) and VI01 [ΔrpoN] (▲) are expressed as 
log10 CFU/gram of harvested tissue. The horizontal line represents the median value for 
each group.  Mann-Whitney test was used to determine significance and is indicated as 
follows: **, significant p-value less than 0.05 relative to V583; *, significant p value less 
than 0.1 relative to V583.   
 
Figure 3-8 Enterococcal burden in rabbits infected with E. faecalis strains.    
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Female C57BL/6 mice were euthanized after 48 hours post infection. Bacterial burden is 
expressed in logarithmic scale for wild type V583, VI01 [ΔrpoN] and EH01 [ΔccpA] in 
(A) implanted catheters retrieved from the mice and (B) homogenized bladders. The 
horizontal bar represents the median of each group of mice. Statistical significance as 
determined by Mann-Whitney test is represented as follows:  **, significant p value less 
than 0.05 relative to V583; ***, significant p value less than 0.005 relative to V583. 
 
 
 
 
 
 
 
 
Figure 3-9 RpoN and CcpA contribute to enterococcal virulence in the murine 
model of CAUTI.  
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3.5 Discussion 
Binding sites for a consensus sequence (TTGGCACNNNNNTTGCT) recognized 
by sigma 54 (RpoN) have been identified upstream of genes predicted to encode sugar 
PTS systems (Mpt, Mpo, Lpo and Mph) in E. faecalis.  The mesentericin Y105 (a class 
IIa bacteriocin) resistance phenotype of an rpoN mutant (29) has also been linked to the 
RpoN-dependent regulation of the mpt operon (27). In the present study, the mptBADC 
operon was approximately 100-fold downregulated in an rpoN mutant when grown in the 
presence of 100 mM glucose compared to the parental strain V583, and likely explains 
the growth defects observed in CDM media with glucose or mannose as the major carbon 
source. This is also in agreement with the observation that an mptR mutant is also 
impaired for growth on mannose and glucose, whereas the other genes encoding EBPs 
grow similar to the parental strain in either glucose or mannose (Supplemental Figure 
3-1). It also suggests that glucose uptake and metabolism in E. faecalis is primarily 
dependent on the Mpt permease. We have previously shown that VI01 (ΔrpoN) is 
resistant to 2-deoxyglucose (a toxic homologue of glucose; 2DG) (26) and mutants 
resistant to 2DG have been shown to localize mutations within mptR or the mptBACD 
genes (27, 49) thus strengthening the notion that Mpt is the major glucose uptake system 
in E. faecalis.   
Mpt has been the most extensively studied PTS system regulated by RpoN in E. 
faecalis (27, 30, 50).  In a study designed to identify EBPs for σ54 in E. faecalis (27), 
Héchard et al. described five activator proteins in the E. faecalis V583 genome. However, 
in the genome sequence immediately downstream of one of the activators, XpoR, the σ54 
consensus binding site was not detected and no putative PTS operon was found. 
Moreover, the gene xpoR was shown to be interrupted by an insertion element.  Our 
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microarray analysis revealed the presence of a putative PTS operon (ef3210-ef3213) 
upstream of xpoR which was approximately six-fold downregulated in an rpoN mutant 
suggesting that this operon is induced in the presence of RpoN under the conditions 
tested here. Furthermore, a sigma 54 binding site with 100% match to the consensus 
sequence was identified upstream of ef3210, the first gene of the operon implying a 
potential role for RpoN in the expression of this operon.  Comparison of the xpoR 
sequence in other E. faecalis genomes revealed that only V583 possesses the transposon 
insertion, and that this insertion likely dissociated the domains of XpoR into two separate 
gene products (EF3214 and EF 3216).  EF3214 is a DEAH-box family ATP dependent 
helicase which is a characteristic of the E. faecalis RpoN activator proteins while EF3216 
is a putative DNA binding protein. Most activator proteins are located upstream of the 
genes they regulate but in some instances activators are also found downstream of the 
genes they regulate (51). Also some organisms encode functional EBPs that lack the 
DNA binding domains (52-54) and experimentally truncated activator proteins that lack 
one of the two domains have also been shown to stably aid in open complex formation 
(51). Whether these two proteins EF3214 and EF3216 still function as an XpoR 
equivalent remains to be determined.    
One of the common themes observed with the transcriptional profile of the rpoN 
and mptD mutants was the significant up-regulation of genes with predicted cre sites, 
suggestive of an involvement with the major catabolite control protein CcpA.  Amongst 
the cohort of cre-regulated genes, we focused our attention on three gene clusters 
encoding endo glycosyl hydrolases (endoglycosidases).  Endoglycosidases are enzymes 
that function to release oligosaccharides from glycoproteins or glycolipids, and do not 
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require the presence of a terminal sugar residue to affect cleavage, thus distinguishing 
them from known exoglycosidases.. The endoglycosidases also serve to release available 
nutrients from the host, and can therefore be thought of as nutrient acquisition systems.  
The genes for each of the endoglycosidases under study (ef0114 [ndoE]; ef0362-61 
[chiBA] and ef2863) were ~ 50-fold upregulated in the rpoN deletion mutant compared to 
V583. Both EF0114 and EF2863 have previously been shown to possess endoglycosidase 
activity (47, 48, 55) and purified EF0362-61 has been shown to possess chitinolytic 
activity (45). Isogenic deletion mutants of the aforementioned endoglycosidases in a ccpA 
mutant background revealed that EF2863 is the major endoglycosidase for the high-
mannose containing glycoprotein RNase B, whereas EF0114 appears to only play a 
minor role in this context. Work by Collin and Fischetti (48) demonstrated glycosyl 
hydrolase activity towards RNase B for EF0114, that they designated EndoE.  The 
relative contribution of EndoE to RNase B deglycosylation in the context of other 
glycosyl hydrolases produced by E. faecalis was however not assessed in their study (48).    
While we did not observe a substantial contribution from EF0114 in the RNase B assay, 
we were able to detect a small accumulation of deglycosylated RNase B in strain IH12 
(ΔccpAΔef0362-61Δef2863), suggesting that this activity might be attributed to EF0114 
(data not shown).  Collin et al. also established a role for EndoE from E. faecalis in the 
deglycosylation of human IgG, suggesting that EndoE might play a role in immune 
evasion.  Recent work by Flock et al. (56) demonstrated that an endoglycosidase 
targeting IgG served as a viable vaccine candidate against Streptococcus equi infection, 
and that antibodies against EndoSe were also cross-protective against Streptococcus 
pyogenes challenge.  The E. faecalis EndoE (EF0114) shares 42% sequence similarity 
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with the endoglycosidases from both S. equi and S. pyogenes. Whether EndoE also 
contributes to immune evasion by E. faecalis awaits further study, and will be a 
component of ongoing studies in the lab.      
In Listeria monocytogenes (57, 58) and Legionella pneumophila (59), the 
chitinase gene products (ChiA and ChiB) contribute to infection outcome in mouse 
models.  EF0362 shares 47% sequence identity with the ChiB from L. monocytogenes 
and EF0361 shares 65% sequence identity with ChiA. On the basis of the sequence 
conservation between these resident Gram-positive enteric species, we anticipate that 
EF0362-61 will likely play a role in nutrient acquisition in the intestinal environment, but 
the nature of the substrates that it works on remain to be defined.     
In order to assess the role of RpoN in E. faecalis virulence, we used a rabbit 
model of endocarditis and CAUTI in mice.  On the basis of bacterial burden, the rpoN 
mutant was significantly attenuated in comparison to the wild type in both the models 
tested. The carbon catabolite protein A (CcpA) mutant in E.faecalis V583 was also tested 
for its ability to cause an infection in the catheter associated urinary tract infection model 
as several genes that were differentially regulated in the rpoN and mptD mutant appeared 
to be regulated by CcpA due to the presence of cre sites proximal to predicted promoter 
regions in the regulated genes. In the catheter associated UTI model, the ccpA mutant was 
also attenuated in comparison to the wild type.  We previously showed that deleting rpoN 
in E. faecalis does not impact the growth of the organism in enriched medium such as 
TSB or THB (26). However, in vivo the organism will face more hostile growth 
conditions, as preferable nutrient sources are kept at growth limiting conditions (i.e. 
glucose is present in normal human serum at 4-8 mM (60) and similar blood glucose 
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levels are also observed in rabbits (61).  The ability of microorganisms to adapt and grow 
in such limiting conditions will determine their infection potential. Our assessment of the 
rpoN mutant for its growth ability in a chemically defined medium with varying glucose 
concentration revealed that in lower glucose concentration (10 and 50 mM), the rpoN 
mutant grows poorly (as measured by absorbance at 600 nm) in comparison to the 
parental strain.  This growth defect is less pronounced but still readily distinguishable 
from the parent strain at higher glucose concentrations (100-200 mM).  The poor growth 
under limiting glucose concentrations likely explains the rpoN mutant’s attenuated 
phenotype in vivo.   
In contrast to the poor growth observed for the rpoN mutant in CDM + glucose, a 
ccpA mutant displays growth defects at higher glucose concentrations (50-200 mM), 
indicative of a metabolic overload (Supplemental Figure 3-2).  A similar growth defect is 
also observed for the ccpA mutant under high concentrations of mannose (Supplemental 
Figure 3-3) or N-acetylglucosamine (Supplemental Figure 3-4) as the principal carbon 
source.  The disregulation of normal metabolism that would occur in a ccpA mutant likely 
explains its attenuated phenotype and is consistent with a growing body of evidence for 
the role of CcpA in Gram-positive bacterial pathogenesis (24, 62, 63).  .  So despite the 
fact that nutrient acquisition systems are overexpressed in a ccpA mutant, including 
endoglycosidases that would likely contribute to immune evasion (EndoE), this mutant 
performs poorly in vivo.  We hypothesize that a redox imbalance in the ccpA mutant 
would contribute to hypersensitivity to oxidative stress, as this has been recently 
observed in a S. pyogenes colonization model (63).   We will be investigating this line of 
evidence in future studies.  Collectively, the observations with the rpoN and ccpA 
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mutants both in vitro and in vivo suggest that regulated metabolism is key to successful 
colonization and infection.  Too little nutrient acquisition of essential sugars in the case 
of rpoN and overactive metabolism in ccpA, results in poor fitness compared to the 
parental strain.         
We present a model for how RpoN and CcpA interface in the cell to regulate 
central carbon metabolism.  In the presence of high glucose concentrations (100-200), the 
growth defect in both the mptR and rpoN mutants appeared to be partially rescued 
suggesting that at higher concentrations, glucose is being transported via other uptake 
systems. The upregulation of several PTS systems and transport proteins in the rpoN 
mutant gives credence to this hypothesis.  Of note is gene ef1516 which encodes an 
EIIABC multi-domain PTS component, and is 14.22 fold upregulated in the rpoN mutant 
and was also found to be upregulated in the mptD mutant (30).  EF1516 shares 57% 
sequence similarity and 39% identity with PtsG, a known glucose specific transporter in 
Bacillus subtilis (64) that possesses all the functional domains of the Enzyme II 
components of a typical PTS in a single protein, and perhaps represents the ancestral 
glucose transporter.  We hypothesize that Mpt might confer a growth advantage to E. 
faecalis enabling the organism the ability to outcompete other microflora for limited 
supplies of glucose.  This enhanced growth may also be the reason why the Mpt PTS is 
targeted by class IIa and IIc bacteriocins to prevent outgrowth of the organism by 
competitors.  In the absence of a functional Mpt, the ancestral glucose transporter 
EF1516 could substitute a redundant role, but only when glucose is in excess.   In the 
absence of RpoN there could be an alteration in the relative abundance of the glycolytic 
intermediates glucose-6-phosphate and fructose-1,6,-bisphosphate within the cell 
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indicating insufficient carbon flow which would trigger the phosphatase activity of  the 
bifunctional enzyme HprK/P that dephosphorylates the PTS intermediate Hpr(Ser-P) 
(Figure 3-10). A dephosphorylated Hpr no longer binds to the catabolite control protein A 
(CcpA), and the dissociation of the Hpr(Ser-P) – CcpA complex would alleviate the 
repression of transcription of cre-regulated genes (39).  In the ΔrpoN mutant, the carbon 
catabolite repression (CCR) may be perpetually derepressed, and the array data with 
respect to cre site containing genes is consistent with this interpretation. The CCR 
derepression can also be attributed in part to the RpoN-regulated mpt operon because cre 
sites have also been identified upstream of genes that are also differentially expressed in 
an mptD/mptR mutant transcriptional microarray (30) (Supplemental Table 3-4).  
In addition to PTS systems and transport proteins, several proteins with regulatory 
functions were also differentially expressed (Supplemental Table 3-1). The differential 
expression of several genes in the rpoN mutant may be attributed to their dependence on 
these transcription regulators. 
Thus the transcription profile of rpoN mutant clearly shows that this sigma factor 
contributes to several diverse functions in enterococcal biology in addition to controlling 
the four known PTS systems. Approximately 10% of the genome is differentially 
regulated by RpoN and understanding these complex metabolic circuits controlled by 
RpoN that feed into the virulence potential of E. faecalis is the focus of ongoing studies. 
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Figure 3-10 Model for sigma 54 mediated carbon catabolite repression (CCR). 
Panel A: Regulation of CCR dependent genes in wild type E. faecalis V583; Panel B Alleviation of CCR in an rpoN mutant or 
mptR/mptD mutant. 
CcpA, Catabolite Control Protein A; mpt, Mannose PTS; cre, catabolite responsive elements; Hpr, Histidine containing 
phosphocarrier protein; EI, Enzyme I; EII, Sugar specific multidomain enzyme II; HprK/P, Bifunctional ATP-dependent Hpr 
kinase/phosphatase; ATP, Adenosine triphosphate; ADP, Adenosine diphosphate. 
A B 
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3.8 Supplemental Tables 
Supplemental Table 3-1 Differentially expressed genes in VI01[ΔrpoN mutant] 
compared to V583 expressed as fold change. 
Gene Function 
Fold 
change 
HYPOTHETICAL PROTEINS AND PROTEINS WITH UNKNOWN FUNCTIONS 
EF0054 hypothetical protein 58.53 
EF0713 conserved hypothetical protein 58.00 
EF0384 hypothetical protein 34.97 
EF0711 conserved hypothetical protein 32.33 
EF1394 conserved hypothetical protein 29.49 
EF0383 protein FdrAconserved hypothetical protein 29.34 
EF0714 hypothetical protein 29.26 
EF0664 hypothetical protein 27.97 
EF1227 conserved hypothetical protein 21.74 
EF2569 conserved hypothetical protein 21.29 
EF2570 aldehyde oxidoreductase, putative 21.17 
EF1226 oxidoreductase, putative 21.02 
EF2566 conserved hypothetical protein 19.48 
EF2568 aminotransferase, class V 18.70 
EF2220 conserved hypothetical protein 18.53 
EF2236 conserved hypothetical protein 18.24 
EF0678 acetyltransferase, GNAT family 16.96 
EF0743 hypothetical protein 16.44 
EF0392 hypothetical protein 15.39 
EF2564 conserved domain protein 14.57 
EF0108 C4-dicarboxylate transporter, putative 13.04 
EF2565 conserved hypothetical protein 12.22 
EF2563 conserved hypothetical protein 11.38 
EF3142 6-phosphogluconate dehydrogenase family protein 8.83 
EF2576 hypothetical protein 8.60 
EF1237 conserved hypothetical protein 8.26 
EF3105 hypothetical protein 7.74 
EF0390 N-acyl-D-amino-acid deacylase family protein 7.61 
EF1912 ROK family protein 7.19 
EF2237 lipoprotein, putative 7.17 
EF0405 hydrolase, haloacid dehalogenase-like family 7.16 
EF1229 conserved hypothetical protein 6.71 
EF1035 lipoprotein, putative 6.62 
EF1066 hexapeptide-repeat containing-acetyltransferase 6.47 
EF3087 hypothetical protein 6.39 
EF1228 hypothetical protein 6.29 
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EF0389 membrane protein, putative 6.19 
EF1919 acetyltransferase, GNAT family 5.87 
EF0377 ankyrin repeat family protein 5.56 
EF2441 conserved hypothetical protein 5.50 
EF0052 hypothetical protein 5.41 
EF3088 hypothetical protein 5.34 
EF1075 acetyltransferase, GNAT family 5.25 
EF0808 hypothetical protein 5.24 
EF1077 acetyltransferase, GNAT family 5.09 
EF3103 membrane protein, putative 5.04 
EF1503 fructose-1,6-bisphosphatase, putative 4.95 
EF3326 conserved hypothetical protein 4.85 
EF3102 hypothetical protein 4.82 
EF2268 conserved hypothetical protein 4.73 
EF2440 celC-related protein 4.71 
EF1359 conserved hypothetical protein 4.70 
EF1360 dihydroxyacetone kinase family protein 4.70 
EF1535 conserved hypothetical protein 4.69 
EF1061 N-acyl-D-amino-acid deacylase family protein 4.53 
EF2581 oxidoreductase, pyridine nucleotide-disulfide family 4.41 
EF0062 5-nucleotidase family protein 4.40 
EF2577 aspartateornithine carbamoyltransferase family protein 4.30 
EF1230 hypothetical protein 4.28 
EF3092 glyoxalase family protein 4.16 
EF2996 conserved hypothetical protein 4.13 
EF1407 hypothetical protein 4.07 
EF1800 conserved hypothetical protein 4.01 
EF1361 dihydroxyacetone kinase family protein 3.84 
EF3032 conserved hypothetical protein 3.77 
EF0459 glucokinase regulator-related protein 3.77 
EF_B0056_x_at hypothetical protein 3.72 
EF3158 hydrolase, haloacid dehalogenase-like family 3.69 
EF1062 N-acyl-D-amino-acid deacylase family protein 3.68 
EF3008 conserved hypothetical protein 3.56 
EF0244 acetyltransferase, GNAT family 3.54 
EF0460 conserved hypothetical protein 3.48 
EF2994 aminotransferase, class V 3.41 
EF1362 conserved domain protein 3.41 
EF1933 hypothetical protein 3.39 
EF1512 conserved hypothetical protein 3.37 
EF0113 hypothetical protein 3.35 
EF0382 conserved hypothetical protein 3.32 
EF1322 conserved hypothetical protein 3.31 
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EF3101 conserved domain protein 3.26 
EF1959 conserved domain protein 3.23 
EF3009 conserved hypothetical protein 3.20 
EF3007 conserved hypothetical protein 3.15 
EF1239 conserved hypothetical protein 3.08 
EF1707 glycosyl hydrolase, family 38 3.07 
EF3010 conserved hypothetical protein 3.05 
EF2933 DNA-binding protein,putative 3.03 
EF1528 hypothetical protein 3.01 
EF3245 cell-envelope associated acid phosphatase -3.10 
EF2944 hypothetical protein -3.10 
EF0708 conserved hypothetical protein -3.16 
EF1198 conserved hypothetical protein -3.26 
EF0672 hypothetical protein -3.31 
EF0341 hypothetical protein -3.33 
EF1168 hypothetical protein -3.40 
EF3207 dihydrouridine synthase family protein -3.64 
EF1968 conserved hypothetical protein -3.66 
EF2500 GcvH family protein -3.69 
EF1841 HD domain protein -3.79 
EF1199 conserved hypothetical protein -4.04 
EF0443 LysM domain protein -4.25 
EF0747 conserved hypothetical protein -4.26 
EF2899 oxidoreductase, pyridine nucleotide-disulfide family -4.35 
EF0419 conserved hypothetical protein -4.54 
EF0634 decarboxylase, putative -4.90 
EF2750 conserved hypothetical protein -4.95 
EF1258 hypothetical protein -5.02 
EF1812 hypothetical protein -5.03 
EF3244 hypothetical protein -5.05 
EF2216 conserved domain protein -5.66 
EF2214 glyoxylase family protein -6.21 
EF2215 conserved hypothetical protein -7.27 
EF2896 hypothetical protein -7.39 
EF0083 hypothetical protein -7.77 
EF1231 conserved hypothetical protein -10.70 
EF0802 hypothetical protein -29.61 
      
TRANSPORT AND BINDING PROTEINS 
EF2223 ABC transporter, permease protein 257.25 
EF2221 ABC transporter, substrate-binding protein 128.09 
EF2222 ABC transporter, permease protein 114.80 
EF0892 amino acid ABC transporter, ATP-binding protein 40.84 
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EF0893 
amino acid ABC transporter, amino acid-bindingpermease 
protein 39.81 
EF1927 glycerol uptake facilitator protein 36.40 
EF0385 major facilitator family transporter 27.11 
EF1398 molybdenum ABC transporter, permease protein 26.30 
EF1397 
molybdenum ABC transporter, molybdenum-binding 
protein 23.85 
EF2234 sugar ABC transporter, sugar-binding protein, putative 17.24 
EF0387 sodiumdicarboxylate symporter family protein 16.14 
EF1233 ABC transporter, permease protein 13.83 
EF1920 C4-dicarboxylate anaerobic carrier 13.23 
EF1399 
molybdenum ABC transporter, ATP-binding protein, 
putative 13.10 
EF0938 ABC transporter, ATP-bindingTOBE domain protein 12.53 
EF1234 ABC transporter, substrate-binding protein, putative 12.52 
EF1345 sugar ABC transporter, sugar-binding protein 11.76 
EF1344 sugar ABC transporter, permease protein 10.11 
EF1232 ABC transporter, permease protein 8.63 
EF1207 citrate carrier protein, CCS family 8.54 
EF2233 ABC transporter, permease protein 8.46 
EF2992 major facilitator family transporter 7.38 
EF3327 citrate transporter 7.22 
EF0556 xylose isomerase 7.01 
EF1343 sugar ABC transporter, permease protein 6.65 
EF1400 cadmium-translocating P-type ATPase 6.43 
EF3104 ABC transporter, ATP-binding protein 5.46 
EF2442 phosphate transporter family protein 5.45 
EF3000 
cytosinepurines, uracil, thiamine, allantoin permease family 
protein 4.56 
EF1513 pheromone binding protein 4.23 
EF2232 ABC transporter, permease protein 4.20 
EF3109 peptide ABC transporter, ATP-binding protein 4.07 
EF3108 peptide ABC transporter, permease protein 3.84 
EF3110 peptide ABC transporter, ATP-binding protein 3.53 
EF1060 pheromone binding protein 3.49 
EF0063 pheromone binding protein, putative 3.42 
EF3107 peptide ABC transporter, permease protein 3.40 
EF3106 peptide ABC transporter, peptide-binding protein 3.35 
EF0243 
branched-chain amino acid transport system II carrier 
protein 3.22 
EF0429 TRAP dicarboxylate transporter, DctP subunit 3.16 
EF0807 pheromone binding protein, putative 3.15 
EF2593 ABC transporter, ATP-bindingpermease protein -3.05 
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EF0569 potassium-transporting ATPase, subunit C -3.16 
EF3069 formatenitrite transporter family protein -3.16 
EF0804 amino acid ABC transporter, amino acid-binding protein -3.19 
EF0568 potassium-transporting ATPase, subunit B -3.37 
EF0805 amino acid ABC transporter, ATP-binding protein -3.56 
EF3004 sulfate transporter familySTAS domain protein -3.57 
EF0806 amino acid ABC transporter, permease protein -3.72 
EF0420 drug resistance transporter, EmrBQacA family protein -3.84 
EF0567 potassium-transporting ATPase, subunit A -3.95 
EF1304 magnesium-translocating P-type ATPase -4.12 
EF0635 amino acid permease family protein -5.11 
EF1053 ABC transporter, ATP-binding protein -5.23 
EF0636 Na+H+ antiporter -6.49 
EF0082 major facilitator family transporter -6.82 
EF1814 drug resistance transporter, EmrBQacA family protein -8.11 
EF1192 aquaporin Z -11.87 
EF1054 ABC transporter, permease protein -17.50 
      
CELL ENVELOPE 
EF0362 chitin binding protein, putative 83.75 
EF0361 chitinase, family 2 69.31 
EF0114 glycosyl hydrolase, family 20 48.20 
EF1657 membrane protein, putative 5.80 
EF0673 membrane protein, putative 4.05 
EF2662 choline binding protein 3.50 
EF2627 teichoic acid glycosylation protein, putative -3.11 
EF1340 pheromone cAM373 precursor lipoprotein -3.16 
EF2746 dltD protein -3.45 
EF0468 LemA family protein -3.71 
EF2749 D-alanine-activating enzyme, putative -3.83 
EF2748 basic membrane protein DtlB -4.01 
EF2747 D-alanyl carrier protein -4.07 
EF0746 penicillin-binding protein, putative -11.48 
      
ENERGY METABOLISM 
EF2863 endo-beta-N-acetylglucosaminidase 62.34 
EF1929 glycerol kinase 53.22 
EF1928 alpha-glycerophosphate oxidase 43.44 
EF0253 aldehyde dehydrogenase 35.88 
EF2562 Flavodoxin 19.95 
EF0106 carbamate kinase 19.07 
EF1068 aldose 1-epimerase 18.97 
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EF0677 phosphoglucomutasephosphomannomutase family protein 18.13 
EF0386 carbamate kinase 16.90 
EF0104 arginine deiminase 15.83 
EF1661 
branched-chain alpha-keto acid dehydrogenase, E3 
component, dihydrolipoamide dehydrogenase 14.95 
EF1658 
branched-chain alpha-keto acid, E2 component, 
dihydrolipoamide acetyltransferase 14.28 
EF3135 mannonate dehydratase, putative 13.37 
EF3134 
2-dehydro-3-deoxyphosphogluconate aldolase4-hydroxy-2-
oxoglutarate aldolase 10.43 
EF2559 
pyruvate flavodoxinferredoxin oxidoreductase family 
protein 9.99 
EF0388 ureidoglycolate dehydrogenase 9.27 
EF1659 
branched-chain alpha-keto acid dehydrogenase, E1 
component, beta subunit 8.46 
EF1349 glycosyl hydrolase, family 13 7.96 
EF2235 glucuronyl hydrolase, putative 7.81 
EF1824 
glycosyl hydrolase, family 31fibronectin type III domain 
protein 6.82 
EF0900 aldehyde-alcohol dehydrogenase 6.69 
EF1206 malate dehydrogenase, decarboxylating 6.26 
EF2579 diaminopropionate ammonia-lyase, putative 6.21 
EF1236 acetyl xylan esterase, putative 5.82 
EF3325 
sodium ion-translocating decarboxylase, biotin carboxyl 
carrier protein 5.29 
EF1347 glycosyl hydrolase, family 13 5.18 
EF1660 
branched-chain alpha-keto acid dehydrogenase, E1 
component, alpha subunit 5.14 
EF1662 butyrate kinase 5.13 
EF1805 glycosyl hydrolase, family 35 4.81 
EF2575 carbamate kinase 4.52 
EF0271 glycosyl hydrolase, family 1 4.33 
EF0291 glycosyl hydrolase, family 1 4.06 
EF0551 glycosyl hydrolase, family 31 3.89 
EF2265 carbohydrate kinase, pfkB family 3.88 
EF2264 4-deoxy-l-threo-5-hexosulose-uronate ketol-isomerase 3.87 
EF1238 glycosyl hydrolase, family 3 3.79 
EF3157 glycosyl hydrolase, family 65 3.78 
EF2272 glucuronyl hydrolase, putative 3.74 
EF1348 glucan 1,6-alpha-glucosidase, putative 3.61 
EF2709 glycosyl hydrolase, family 2 3.56 
EF1158 N4-(beta-N-acetylglucosaminyl)-L-asparaginase, putative 3.52 
EF1071 galactose-1-phosphate uridylyltransferase 3.33 
EF2646 glycerate kinase, putative 3.32 
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EF1069 Galactokinase 3.17 
EF2722 L-serine dehydratase, iron-sulfur-dependent, alpha subunit -3.19 
EF2721 L-serine dehydratase, iron-sulfur-dependent, beta subunit -3.77 
      
PTS SYSTEMS 
EF2213 PTS system, IIBC components 23.30 
EF3138 PTS system, IID component 17.41 
EF3137 PTS system, IIB component 16.00 
EF1516 PTS system, IIABC components 14.22 
EF3136 PTS system, IIA component 12.08 
EF0553 PTS system, IID component 11.35 
EF0554 PTS system, IIB component 9.60 
EF1529 PTS system, IIC component, putative 8.56 
EF1803 PTS system, IIC component 8.28 
EF_A0067_at PTS system, IIABC components 7.93 
EF3139 PTS system, IIC component 7.55 
EF1802 PTS system, IID component 7.35 
EF3031 PTS system, IIB component 7.03 
EF0270 PTS system, beta-glucoside-specific IIABC component 6.91 
EF0292 PTS system, IIC component 6.62 
EF1804 PTS system, IIB component 6.36 
EF0552 PTS system, IIC component 6.21 
EF1836 PTS system, IIA component, putative 5.84 
EF1837 PTS system, IIB component, putative 5.74 
EF0816 PTS system, IIC component 5.32 
EF3030 PTS system, IIC component 4.58 
EF1801 PTS system, IIA component 4.42 
EF3029 PTS system, IID component 4.32 
EF2269 PTS system, IID component 4.14 
EF0958 PTS system, IIABC components 3.91 
EF0815 PTS system, IIAB components 3.81 
EF0817 PTS system, IID component 3.77 
EF0555 PTS system, IIA component 3.75 
EF0456 PTS system, IID component 3.75 
EF2270 PTS system, IIC component 3.59 
EF2267 PTS system, IIA component 3.42 
EF1018 PTS system, IIA component -3.05 
EF1019 PTS system, IIC component -4.12 
EF3213 PTS system, IID component -4.30 
EF1017 PTS system, IIB component -4.49 
EF3212 PTS system, IIC component -5.34 
EF3210 PTS system, IIA component, putative -6.27 
EF3211 PTS system, IIB component -6.57 
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EF0020 PTS system, mannose-specific IIAB components -90.38 
EF0021 PTS system, mannose-specific IIC component -100.36 
EF0022 PTS system, mannose-specific IID component -107.49 
EF0019 PTS system, IIB component -152.11 
      
REGULATORY FUNCTIONS 
EF0107 transcriptional regulator, CrpFnr family 18.06 
EF1515 transcription antiterminator, bglG family 14.09 
EF0432 transcriptional regulator, AraC family 12.37 
EF1656 transcriptional regulator, LysR family 8.75 
EF1591 transcriptional regulator, AraC family 8.39 
EF3144 
phosphosugar-binding transcriptional regulator, RpiR 
family 8.25 
EF2711 transcriptional regulator, AraC family 7.88 
EF0103 transcriptional regulator, ArgR family 5.68 
EF0102 transcriptional regulator, ArgR family 3.33 
EF3328 transcriptional regulator, GntR family 3.07 
EF0676 arginine repressor 3.05 
EF2594 transcriptional regulator, TetR family -3.45 
EF2703 transcriptional regulator -4.07 
EF1302 transcriptional regulator, putative -4.41 
EF1224 transcriptional regulator, CroCI family -4.56 
EF1303 transcriptional regulator, LysR family -4.92 
EF0782 RNA polymerase sigma-54 factor -132.88 
      
CELLULAR PROCESSES 
EF0439 immunity protein PlnM, putative 13.54 
EF3023 polysaccharide lyase, family 8 8.85 
EF1076 streptomycin 3-adenylyltransferase, putative 5.84 
EF0818 polysaccharide lyase, family 8 3.61 
EF1502 beta-lactamase, putative 3.25 
EF2739 alkyl hydroperoxide reductase, C subunit -3.04 
EF1300 cell division protein, FtsWRodASpovE family -3.69 
EF1301 cell division protein, FtsWRodASpovE family -3.89 
      
AMINOACID BIOSYNTHESIS 
EF0891 aspartate aminotransferase, putative 47.93 
EF0105 ornithine carbamoyltransferase 19.35 
EF2560 glutamate synthase (NADPH), homotetrameric 10.50 
      
TWO COMPONENT SYSTEMS 
EF2218 DNA-binding response regulator, AraC family 12.18 
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EF2219 sensor histidine kinase 11.03 
      
BIOSYNTHESIS OF COFACTORS,PROSTHETIC GROUPS AND CARRIERS 
EF1395 molybdenum cofactor biosynthesis family protein 38.35 
EF1396 molybdenum cofactor biosynthesis family protein, putative 35.07 
EF1393 molybdopterin cofactor biosynthesis protein A, putative 30.09 
EF1225 thiamin biosynthesis ApbE, putative 23.88 
EF1392 molybdenum cofactor biosynthesis protein MoaC 4.44 
EF1655 2-dehydropantoate 2-reductase, putative 4.30 
EF1391 molybdenum cofactor biosynthesis family protein 3.06 
EF1969 phosphomethylpyrimidine kinase, putative -3.38 
EF2445 2-dehydropantoate 2-reductase, putative -4.14 
      
DNA METABOLISM 
EF0053 DNA polymerase III, epsilon subunit 7.74 
      
TRANSCRIPTION 
EF0115 endoribonuclease L-PSP, putative 30.17 
EF3214 ATP-dependent helicase, DEAH-box family, putative -3.63 
      
PRYRIMIDINE RIBONUCLEOTIDE BIOSYNTHESIS 
EF2561 
dihydroorotate dehydrogenase electron transfer subunit, 
putative 13.65 
EF2999 allantoinase, putative 5.82 
      
NUCLEOTIDE RELATED 
EF1921 inosine-uridine preferring nucleoside hydrolase 15.75 
EF1036 nucleoside diphosphate kinase 11.54 
EF2580 D-hydantoinase 6.39 
EF1958 deoxyguanosinetriphosphate triphosphohydrolase, putative 3.61 
      
CENTRAL INTERMEDIARY METABOLISM 
EF3141 
D-isomer specific 2-hydroxyacid dehydrogenase family 
protein 16.20 
EF0895 glycerol dehydrogenase, putative 15.54 
EF3140 alcohol dehydrogenase, iron-containing 9.99 
EF1358 glycerol dehydrogenase, putative 4.88 
EF1364 
acetyl-CoA acetyltransferasehydroxymethylglutaryl-CoA 
reductase, degradative -3.41 
EF1813 sulfatase domain protein -11.88 
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PHAGE PROTEINS 
EF0354 holin, putative -3.02 
EF0339 major capsid protein, putative -3.15 
      
FATTY ACID AND PHOSPHOLIPID METABOLISM 
EF1663 branched-chain phosphotransacylase 10.28 
      
PROTEIN SYNTHESIS AND FATE 
EF2567 selenide, water dikinase 16.82 
EF2471 arginyl-tRNA synthetase 7.80 
EF2997 peptidase, M20M25M40 family 3.64 
EF2578 peptidase, M20M25M40 family 3.02 
EF2858 threonyl-tRNA synthetase -3.14 
EF0633 tyrosyl-tRNA synthetase -4.39 
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Supplemental Table 3-2 Genes common to the transcriptional profile of VI01 & 
V583::mptD 
Gene Function 
Fold 
change 
EF2223 ABC transporter, permease protein 257.25 
EF2221 ABC transporter, substrate-binding protein 128.09 
EF2222 ABC transporter, permease protein 114.80 
EF0362 chitin binding protein, putative 83.75 
EF0361 chitinase, family 2 69.31 
EF2863 endo-beta-N-acetylglucosaminidase 62.34 
EF0054 hypothetical protein 58.53 
EF1929 glycerol kinase 53.22 
EF0114 glycosyl hydrolase, family 20 48.20 
EF1928 alpha-glycerophosphate oxidase 43.44 
EF1395 molybdenum cofactor biosynthesis family protein 38.35 
EF1927 glycerol uptake facilitator protein 36.40 
EF1396 molybdenum cofactor biosynthesis family protein, putative 35.07 
EF0115 endoribonuclease L-PSP, putative 30.17 
EF1393 molybdopterin cofactor biosynthesis protein A, putative 30.09 
EF0664 hypothetical protein 27.97 
EF1398 molybdenum ABC transporter, permease protein 26.30 
EF1225 thiamin biosynthesis ApbE, putative 23.88 
EF1397 molybdenum ABC transporter, molybdenum-binding protein 23.85 
EF2569 conserved hypothetical protein 21.29 
EF2570 aldehyde oxidoreductase, putative 21.17 
EF2562 Flavodoxin 19.95 
EF0105 ornithine carbamoyltransferase 19.35 
EF0106 carbamate kinase 19.07 
EF1068 aldose 1-epimerase 18.97 
EF2568 aminotransferase, class V 18.70 
EF2220 conserved hypothetical protein 18.53 
EF0677 phosphoglucomutasephosphomannomutase family protein 18.13 
EF3138 PTS system, IID component 17.41 
EF0678 acetyltransferase, GNAT family 16.96 
EF0743 hypothetical protein 16.44 
EF3141 
D-isomer specific 2-hydroxyacid dehydrogenase family 
protein 16.20 
EF3137 PTS system, IIB component 16.00 
EF0104 arginine deiminase 15.83 
EF1921 inosine-uridine preferring nucleoside hydrolase 15.75 
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EF1516 PTS system, IIABC components 14.22 
EF1515 transcription antiterminator, bglG family 14.09 
EF2561 
dihydroorotate dehydrogenase electron transfer subunit, 
putative 13.65 
EF1920 C4-dicarboxylate anaerobic carrier 13.23 
EF0108 C4-dicarboxylate transporter, putative 13.04 
EF0938 ABC transporter, ATP-bindingTOBE domain protein 12.53 
EF3136 PTS system, IIA component 12.08 
EF1345 sugar ABC transporter, sugar-binding protein 11.76 
EF2563 conserved hypothetical protein 11.38 
EF0553 PTS system, IID component 11.35 
EF2560 glutamate synthase (NADPH), homotetrameric 10.50 
EF3134 
2-dehydro-3-deoxyphosphogluconate aldolase4-hydroxy-2-
oxoglutarate aldolase 10.43 
EF1344 sugar ABC transporter, permease protein 10.11 
EF3140 alcohol dehydrogenase, iron-containing 9.99 
EF2559 pyruvate flavodoxinferredoxin oxidoreductase family protein 9.99 
EF3142 6-phosphogluconate dehydrogenase family protein 8.83 
EF1529 PTS system, IIC component, putative 8.56 
EF1659 
branched-chain alpha-keto acid dehydrogenase, E1 
component, beta subunit 8.46 
EF1237 conserved hypothetical protein 8.26 
EF3144 phosphosugar-binding transcriptional regulator, RpiR family 8.25 
EF1349 glycosyl hydrolase, family 13 7.96 
EF_A0067_at PTS system, IIABC components 7.93 
EF2711 transcriptional regulator, AraC family 7.88 
EF0053 DNA polymerase III, epsilon subunit 7.74 
EF3139 PTS system, IIC component 7.55 
EF1802 PTS system, IID component 7.35 
EF1912 ROK family protein 7.19 
EF0405 hydrolase, haloacid dehalogenase-like family 7.16 
EF3031 PTS system, IIB component 7.03 
EF0270 PTS system, beta-glucoside-specific IIABC component 6.91 
EF1343 sugar ABC transporter, permease protein 6.65 
EF1066 hexapeptide-repeat containing-acetyltransferase 6.47 
EF1206 malate dehydrogenase, decarboxylating 6.26 
EF1919 acetyltransferase, GNAT family 5.87 
EF0377 ankyrin repeat family protein 5.56 
EF2441 conserved hypothetical protein 5.50 
EF2442 phosphate transporter family protein 5.45 
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EF3325 
sodium ion-translocating decarboxylase, biotin carboxyl 
carrier protein 5.29 
EF1347 glycosyl hydrolase, family 13 5.18 
EF1358 glycerol dehydrogenase, putative 4.88 
EF2440 celC-related protein 4.71 
EF1359 conserved hypothetical protein 4.70 
EF1535 conserved hypothetical protein 4.69 
EF1801 PTS system, IIA component 4.42 
EF0271 glycosyl hydrolase, family 1 4.33 
EF3109 peptide ABC transporter, ATP-binding protein 4.07 
EF1800 conserved hypothetical protein 4.01 
EF0958 PTS system, IIABC components 3.91 
EF1361 dihydroxyacetone kinase family protein 3.84 
EF3108 peptide ABC transporter, permease protein 3.84 
EF1238 glycosyl hydrolase, family 3 3.79 
EF3157 glycosyl hydrolase, family 65 3.78 
EF0459 glucokinase regulator-related protein 3.77 
EF0456 PTS system, IID component 3.75 
EF3158 hydrolase, haloacid dehalogenase-like family 3.69 
EF1348 glucan 1,6-alpha-glucosidase, putative 3.61 
EF0818 polysaccharide lyase, family 8 3.61 
EF3110 peptide ABC transporter, ATP-binding protein 3.53 
EF0460 conserved hypothetical protein 3.48 
EF3107 peptide ABC transporter, permease protein 3.40 
EF3106 peptide ABC transporter, peptide-binding protein 3.35 
EF1069 Galactokinase 3.17 
EF3328 transcriptional regulator, GntR family 3.07 
EF1707 glycosyl hydrolase, family 38 3.07 
EF1528 hypothetical protein 3.01 
EF0082 major facilitator family transporter -6.82 
EF0020 PTS system, mannose-specific IIAB components -90.38 
EF0021 PTS system, mannose-specific IIC component -100.36 
EF0022 PTS system, mannose-specific IID component -107.49 
EF0019 PTS system, IIB component -152.11 
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Supplemental Table 3-3 List of genes differentially regulated in VI01[ΔrpoN] but 
not in the V583::mptD mutant. 
 
Gene Function 
Fold 
Change 
EF0713 conserved hypothetical protein 58.00 
EF0891 aspartate aminotransferase, putative 47.93 
EF0892 amino acid ABC transporter, ATP-binding protein 40.84 
EF0893 
amino acid ABC transporter, amino acid-bindingpermease 
protein 39.81 
EF0253 aldehyde dehydrogenase 35.88 
EF0384 hypothetical protein 34.97 
EF0711 conserved hypothetical protein 32.33 
EF1394 conserved hypothetical protein 29.49 
EF0383 protein FdrAconserved hypothetical protein 29.34 
EF0714 hypothetical protein 29.26 
EF0385 major facilitator family transporter 27.11 
EF2213 PTS system, IIBC components 23.30 
EF1227 conserved hypothetical protein 21.74 
EF1226 oxidoreductase, putative 21.02 
EF2566 conserved hypothetical protein 19.48 
EF2236 conserved hypothetical protein 18.24 
EF0107 transcriptional regulator, CrpFnr family 18.06 
EF2234 sugar ABC transporter, sugar-binding protein, putative 17.24 
EF0386 carbamate kinase 16.90 
EF2567 selenide, water dikinase 16.82 
EF0387 sodiumdicarboxylate symporter family protein 16.14 
EF0895 glycerol dehydrogenase, putative 15.54 
EF0392 hypothetical protein 15.39 
EF1661 
branched-chain alpha-keto acid dehydrogenase, E3 component, 
dihydrolipoamide dehydrogenase 14.95 
EF2564 conserved domain protein 14.57 
EF1658 
branched-chain alpha-keto acid, E2 component, 
dihydrolipoamide acetyltransferase 14.28 
EF1233 ABC transporter, permease protein 13.83 
EF0439 immunity protein PlnM, putative 13.54 
EF3135 mannonate dehydratase, putative 13.37 
EF1399 molybdenum ABC transporter, ATP-binding protein, putative 13.10 
EF1234 ABC transporter, substrate-binding protein, putative 12.52 
EF0432 transcriptional regulator, AraC family 12.37 
EF2565 conserved hypothetical protein 12.22 
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EF2218 DNA-binding response regulator, AraC family 12.18 
EF1036 nucleoside diphosphate kinase 11.54 
EF2219 sensor histidine kinase 11.03 
EF1663 branched-chain phosphotransacylase 10.28 
EF0554 PTS system, IIB component 9.60 
EF0388 ureidoglycolate dehydrogenase 9.27 
EF3023 polysaccharide lyase, family 8 8.85 
EF1656 transcriptional regulator, LysR family 8.75 
EF1232 ABC transporter, permease protein 8.63 
EF2576 hypothetical protein 8.60 
EF1207 citrate carrier protein, CCS family 8.54 
EF2233 ABC transporter, permease protein 8.46 
EF1591 transcriptional regulator, AraC family 8.39 
EF1803 PTS system, IIC component 8.28 
EF2235 glucuronyl hydrolase, putative 7.81 
EF2471 arginyl-tRNA synthetase 7.80 
EF3105 hypothetical protein 7.74 
EF0390 N-acyl-D-amino-acid deacylase family protein 7.61 
EF2992 major facilitator family transporter 7.38 
EF3327 citrate transporter 7.22 
EF2237 lipoprotein, putative 7.17 
EF0556 xylose isomerase 7.01 
EF1824 
glycosyl hydrolase, family 31fibronectin type III domain 
protein 6.82 
EF1229 conserved hypothetical protein 6.71 
EF0900 aldehyde-alcohol dehydrogenase 6.69 
EF0292 PTS system, IIC component 6.62 
EF1035 lipoprotein, putative 6.62 
EF1400 cadmium-translocating P-type ATPase 6.43 
EF2580 D-hydantoinase 6.39 
EF3087 hypothetical protein 6.39 
EF1804 PTS system, IIB component 6.36 
EF1228 hypothetical protein 6.29 
EF0552 PTS system, IIC component 6.21 
EF2579 diaminopropionate ammonia-lyase, putative 6.21 
EF0389 membrane protein, putative 6.19 
EF1076 streptomycin 3-adenylyltransferase, putative 5.84 
EF1836 PTS system, IIA component, putative 5.84 
EF1236 acetyl xylan esterase, putative 5.82 
EF2999 allantoinase, putative 5.82 
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EF1657 membrane protein, putative 5.80 
EF1837 PTS system, IIB component, putative 5.74 
EF0103 transcriptional regulator, ArgR family 5.68 
EF3104 ABC transporter, ATP-binding protein 5.46 
EF0052 hypothetical protein 5.41 
EF3088 hypothetical protein 5.34 
EF0816 PTS system, IIC component 5.32 
EF1075 acetyltransferase, GNAT family 5.25 
EF0808 hypothetical protein 5.24 
EF1660 
branched-chain alpha-keto acid dehydrogenase, E1 component, 
alpha subunit 5.14 
EF1662 butyrate kinase 5.13 
EF1077 acetyltransferase, GNAT family 5.09 
EF3103 membrane protein, putative 5.04 
EF1503 fructose-1,6-bisphosphatase, putative 4.95 
EF3326 conserved hypothetical protein 4.85 
EF3102 hypothetical protein 4.82 
EF1805 glycosyl hydrolase, family 35 4.81 
EF2268 conserved hypothetical protein 4.73 
EF1360 dihydroxyacetone kinase family protein 4.70 
EF3030 PTS system, IIC component 4.58 
EF3000 
cytosinepurines, uracil, thiamine, allantoin permease family 
protein 4.56 
EF1061 N-acyl-D-amino-acid deacylase family protein 4.53 
EF2575 carbamate kinase 4.52 
EF1392 molybdenum cofactor biosynthesis protein MoaC 4.44 
EF2581 oxidoreductase, pyridine nucleotide-disulfide family 4.41 
EF0062 5-nucleotidase family protein 4.40 
EF3029 PTS system, IID component 4.32 
EF1655 2-dehydropantoate 2-reductase, putative 4.30 
EF2577 aspartateornithine carbamoyltransferase family protein 4.30 
EF1230 hypothetical protein 4.28 
EF1513 pheromone binding protein 4.23 
EF2232 ABC transporter, permease protein 4.20 
EF3092 glyoxalase family protein 4.16 
EF2269 PTS system, IID component 4.14 
EF2996 conserved hypothetical protein 4.13 
EF1407 hypothetical protein 4.07 
EF0291 glycosyl hydrolase, family 1 4.06 
EF0673 membrane protein, putative 4.05 
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EF0551 glycosyl hydrolase, family 31 3.89 
EF2265 carbohydrate kinase, pfkB family 3.88 
EF2264 4-deoxy-l-threo-5-hexosulose-uronate ketol-isomerase 3.87 
EF0815 PTS system, IIAB components 3.81 
EF0817 PTS system, IID component 3.77 
EF3032 conserved hypothetical protein 3.77 
EF0555 PTS system, IIA component 3.75 
EF2272 glucuronyl hydrolase, putative 3.74 
EF_B0056 hypothetical protein 3.72 
EF1062 N-acyl-D-amino-acid deacylase family protein 3.68 
EF2997 peptidase, M20M25M40 family 3.64 
EF1958 deoxyguanosinetriphosphate triphosphohydrolase, putative 3.61 
EF2270 PTS system, IIC component 3.59 
EF2709 glycosyl hydrolase, family 2 3.56 
EF3008 conserved hypothetical protein 3.56 
EF0244 acetyltransferase, GNAT family 3.54 
EF1158 N4-(beta-N-acetylglucosaminyl)-L-asparaginase, putative 3.52 
EF2662 choline binding protein 3.50 
EF1060 pheromone binding protein 3.49 
EF0063 pheromone binding protein, putative 3.42 
EF2267 PTS system, IIA component 3.42 
EF2994 aminotransferase, class V 3.41 
EF1362 conserved domain protein 3.41 
EF1933 hypothetical protein 3.39 
EF1512 conserved hypothetical protein 3.37 
EF0113 hypothetical protein 3.35 
EF0102 transcriptional regulator, ArgR family 3.33 
EF1071 galactose-1-phosphate uridylyltransferase 3.33 
EF2646 glycerate kinase, putative 3.32 
EF0382 conserved hypothetical protein 3.32 
EF1322 conserved hypothetical protein 3.31 
EF3101 conserved domain protein 3.26 
EF1502 beta-lactamase, putative 3.25 
EF1959 conserved domain protein 3.23 
EF0243 branched-chain amino acid transport system II carrier protein 3.22 
EF3009 conserved hypothetical protein 3.20 
EF0429 TRAP dicarboxylate transporter, DctP subunit 3.16 
EF0807 pheromone binding protein, putative 3.15 
EF3007 conserved hypothetical protein 3.15 
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EF1239 conserved hypothetical protein 3.08 
EF1391 molybdenum cofactor biosynthesis family protein 3.06 
EF0676 arginine repressor 3.05 
EF3010 conserved hypothetical protein 3.05 
EF2933 DNA-binding protein,putative 3.03 
EF2578 peptidase, M20M25M40 family 3.02 
EF0354 holin, putative -3.02 
EF2739 alkyl hydroperoxide reductase, C subunit -3.04 
EF2593 ABC transporter, ATP-bindingpermease protein -3.05 
EF1018 PTS system, IIA component -3.05 
EF3245 cell-envelope associated acid phosphatase -3.10 
EF2944 hypothetical protein -3.10 
EF2627 teichoic acid glycosylation protein, putative -3.11 
EF2858 threonyl-tRNA synthetase -3.14 
EF0339 major capsid protein, putative -3.15 
EF0708 conserved hypothetical protein -3.16 
EF0569 potassium-transporting ATPase, subunit C -3.16 
EF3069 formatenitrite transporter family protein -3.16 
EF1340 pheromone cAM373 precursor lipoprotein -3.16 
EF0804 amino acid ABC transporter, amino acid-binding protein -3.19 
EF2722 L-serine dehydratase, iron-sulfur-dependent, alpha subunit -3.19 
EF1198 conserved hypothetical protein -3.26 
EF0672 hypothetical protein -3.31 
EF0341 hypothetical protein -3.33 
EF0568 potassium-transporting ATPase, subunit B -3.37 
EF1969 phosphomethylpyrimidine kinase, putative -3.38 
EF1364 
acetyl-CoA acetyltransferasehydroxymethylglutaryl-CoA 
reductase, degradative -3.41 
EF2746 dltD protein -3.45 
EF2594 transcriptional regulator, TetR family -3.45 
EF1168 hypothetical protein -3.46 
EF0805 amino acid ABC transporter, ATP-binding protein -3.56 
EF3004 sulfate transporter familySTAS domain protein -3.57 
EF3214 ATP-dependent helicase, DEAH-box family, putative -3.63 
EF3207 dihydrouridine synthase family protein -3.64 
EF1968 conserved hypothetical protein -3.66 
EF2500 GcvH family protein -3.69 
EF1300 cell division protein, FtsWRodASpovE family -3.69 
EF0468 LemA family protein -3.71 
EF0806 amino acid ABC transporter, permease protein -3.72 
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EF2721 L-serine dehydratase, iron-sulfur-dependent, beta subunit -3.77 
EF1841 HD domain protein -3.79 
EF2749 D-alanine-activating enzyme, putative -3.83 
EF0420 drug resistance transporter, EmrBQacA family protein -3.84 
EF1301 cell division protein, FtsWRodASpovE family -3.89 
EF0567 potassium-transporting ATPase, subunit A -3.95 
EF2748 basic membrane protein DtlB -4.01 
EF1199 conserved hypothetical protein -4.04 
EF2703 transcriptional regulator -4.07 
EF2747 D-alanyl carrier protein -4.07 
EF1019 PTS system, IIC component -4.12 
EF1304 magnesium-translocating P-type ATPase -4.12 
EF2445 2-dehydropantoate 2-reductase, putative -4.14 
EF0443 LysM domain protein -4.25 
EF0747 conserved hypothetical protein -4.26 
EF3213 PTS system, IID component -4.30 
EF2899 oxidoreductase, pyridine nucleotide-disulfide family -4.35 
EF0633 tyrosyl-tRNA synthetase -4.39 
EF1302 transcriptional regulator, putative -4.41 
EF1017 PTS system, IIB component -4.49 
EF0419 conserved hypothetical protein -4.54 
EF1224 transcriptional regulator, CroCI family -4.56 
EF0634 decarboxylase, putative -4.90 
EF1303 transcriptional regulator, LysR family -4.92 
EF2750 conserved hypothetical protein -4.95 
EF1258 hypothetical protein -5.02 
EF1812 hypothetical protein -5.03 
EF3244 hypothetical protein -5.05 
EF0635 amino acid permease family protein -5.11 
EF1053 ABC transporter, ATP-binding protein -5.23 
EF3212 PTS system, IIC component -5.34 
EF2216 conserved domain protein -5.66 
EF2214 glyoxylase family protein -6.21 
EF3210 PTS system, IIA component, putative -6.27 
EF0636 Na+H+ antiporter -6.49 
EF3211 PTS system, IIB component -6.57 
EF2215 conserved hypothetical protein -7.27 
EF2896 hypothetical protein -7.39 
EF0083 hypothetical protein -7.77 
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EF1814 drug resistance transporter, EmrBQacA family protein -8.11 
EF1231 conserved hypothetical protein -10.70 
EF0746 penicillin-binding protein, putative -11.48 
EF1192 aquaporin Z -11.87 
EF1813 sulfatase domain protein -11.88 
EF1054 ABC transporter, permease protein -17.50 
EF0802 hypothetical protein -36.40 
EF0782 RNA polymerase sigma-54 factor -132.88 
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Supplemental Table 3-4 Putative cre sites in differentially expressed genes common to VI01[ΔrpoN] and 
V583::mptD transcriptome. 
Gene Function 
Fold 
change Start End 
Cre sequence 
(WTGWAARCGYWWWCW) 
EF0104  arginine deiminase  15.83 -146 -132 ATGAAAGCGCATTCT 
EFA0067 PTS system, IIABC components  7.93 -154 -140 TAGTAAACGTTTTCT  
EF0054 hypothetical protein   58.53 -92 -78 TCGAAAGCGCTTTCT  
EF0115 endoribonuclease L-PSP, putative  30.17 -49 -35 ATGTAAGCGGAATCA  
EF0362 chitin binding protein, putative  83.75 -41 -27 CTGTAAGCGCATACA  
EF0377 ankyrin repeat family protein 5.56 -295 -287 ATTAAAACGCTTTCT  
EF0405 hydrolase, haloacid dehalogenase-like family 7.16 -71 -57 ATGTAAACGGATTCT  
EF0664 hypothetical protein 27.97 -17 -3 ATGAAAGCGGATACA  
EF0938 
ABC transporter, ATP-bindingTOBE domain 
protein 12.53 -60 -46 ATGAAAACGCTATCT 
EF1800 conserved hypothetical protein 4.01 -41 -27 ATGAAAGCGTGTTCA  
EF2223 ABC transporter, permease protein 257.25 -38 -24 ATGAAAACGCTATTA  
EF2711 transcriptional regulator, AraC family 7.88 -37 -23 ATGTAAAGGCTTTCT  
EF2863 endo-beta-N-acetylglucosaminidase 62.34 -45 -31 TTGTAAGCGCTAACA 
EF3142 6-phosphogluconate dehydrogenase family protein 8.83 
-374 -360 ATGAAAAGGCATTCA  
-68 -34 ATGTAAACGATTACA  
EF3144 
phosphosugar-binding transcriptional regulator, 
RpiR family 8.25 
-359 -345 ATGTAAACGATTACA  
-53 -39 ATGAAAAGGCATTCA  
EF1069 galactokinase 3.17 -109 -95 TTGTACACGTTTTCA  
EF1068 aldose 1-epimerase 18.97 -126 -112 TTGAAAACGTGTACA  
EF1929  glycerol kinase 53.22 
-146 -132 TTGAAAGCGTTGTCT  
-36 -22 TTGAAATCGTTTTCT  
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Supplemental Table 3-5 Putative cre sites in genes exclusive to VI01 [ΔrpoN mutant]
Gene Function 
Fold 
Change Start End 
Cre sequence 
WTGWAARCGYWWWC 
EF0253 aldehyde dehydrogenase 35.88 -38 -24 TTGTAAGCGGATACA  
EF0292 PTS system, IIC component 6.62 -51 -37 ATGTAAACGGATACA  
EF0382 conserved hypothetical protein 3.32 -76 -62 ATGAAAACACTTTCT  
EF0383 protein FdrA conserved hypothetical protein 29.34 -61 -47 ATGAAAACACTTTCT  
EF0439 immunity protein PlnM, putative 13.54 -49 -35 ATGAAAACGTTATCA 
EF1036 nucleoside diphosphate kinase 11.54 -75 -61 ATGAAAGCGGATACT  
EF1207 citrate carrier protein, CCS family 8.54 -53 -39 ATGTAAACGTTTTCT 
EF1232 ABC transporter, permease protein 8.63 -81 -67 ATGTAAGGGTTTACA  
EF1392 molybdenum cofactor biosynthesis protein MoaC 4.44 -38 -24 GTGTAAACGTTAACA  
EF1655 2-dehydropantoate 2-reductase, putative 4.3 -158 -144 TTAAAAGCGCTTACA  
EF1656 transcriptional regulator, LysR family 8.75 -33 -19 TTAAAAGCGCTTACA  
EF1663 branched-chain phosphotransacylase 10.28 -61 -47 ATGTAAACGCATACA 
EF1805 glycosyl hydrolase, family 35 4.81 -30 -16 TTGAAAGCGTTTACT 
EF1824 
glycosyl hydrolase, family 31fibronectin type III 
domain protein 6.82 -255 -241 ATGAAAACGCATTCA 
EF1836 PTS system, IIA component, putative 5.84 -63 -49 TTGAAAGCGTTTTAT  
EF2237 lipoprotein, putative 7.17 -35 -21 ATTAAAGCGCTTTCT  
EF2721 (sdhB2) 
L-serine dehydratase, iron-sulfur-dependent, beta 
subunit -3.77 -33 -19 ATGAAAACATATTCT  
EF3000 
cytosinepurines, uracil, thiamine, allantoin 
permease family protein 4.56 -118 -104 TTGTAAGCGCTTTTT  
EF3023 polysaccharide lyase, family 8 8.85 -209 -195 GTGAAAGCGTAAACA  
EF3087 hypothetical protein 3.62 -102 -88 ATAAAAACGTTTTCT  
EF3088 hypothetical protein 5.34 -58 -44 ATAAAAACGTTTTCT  
EF3326 conserved hypothetical protein 4.85 -373 -359 TTGTAAGCGTTAACA 
EF3327 citrate transporter 7.22 -45 -31 TTGTAAGCGTTAACA 
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3.9 Supplemental Figures 
                           
 
The growth curves are represented as Black: V583, Blue: MG07 [ΔmptR], Red: MG09 
[ΔmpoR]. Green: MG10 [ΔmphR] and Purple, MG08 [ΔlpoR] 
 
Supplemental Figure 3-1 Growth pattern of activator mutants in CDM containing 
10mM glucose; 10mM Mannose or 10mM N-acetlglucosamine. 
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Each graph is the average of ten replicates with standard error of the mean shown.  The 
growth curves are shown in black (V583) and purple (EH01[ΔccpA]). 
 
 
 
 
 
 
Supplemental Figure 3-2 Growth of E.faecalis in chemically defined medium with 
the glucose as the sole carbon source. 
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Each graph is the average of ten replicates with standard error of the mean shown.  The 
growth curves are shown in black (V583) and purple (EH01[ΔccpA]). 
 
 
 
 
 
 
Supplemental Figure 3-3 Growth of E.faecalis in chemically defined medium with 
the mannose as the sole carbon source. 
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Each graph is the average of ten replicates with standard error of the mean shown.  The 
growth curves are shown in black (V583) and purple (EH01[ΔccpA 
 
 
 
 
 
 
Supplemental Figure 3-4 Growth of E.faecalis in chemically defined medium with 
the N-acetylglucosamine (NAG) as the sole carbon source. 
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Chapter 4 -  Novel modification to enterococal cell 
wall architecture regulated by sigma 54.  
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4.1 Introduction 
The bacterial exoskeleton or cell wall protects the bacteria from environmental 
disturbances. It acts as a physical barrier and also relays the changes in the surrounding as 
signals to the interior that then prompts the bacterial response system to take appropriate 
measures to stabilize the cell to the alterations.  In-vivo it protects the cell from the host 
immune system. The enterococcal cell wall is made up of a thick peptidoglycan layer, 
proteins (6), lipoproteins (32), polysaccharides (40), glycolipids (35) and glycopolymer 
such as wall teichoic acid and lipoteichoic acid (34, 39). In several strains of enterococci, 
covering the cell wall and covalently attached to it is a layer of capsular polysaccharide 
which protects the bacteria from opsonophagocytic killing by the host (16, 38). These 
structures function to regulate cells from autolytic breakdown as well as antimicrobial 
peptides encountered by the enterococci in-vivo.  
Specific modification in these components have helped enterococci to resist the 
damage that might be caused by several cell wall targeting agents such as antimicrobial 
peptides and also protect them from the host immune system. For instance, the wall 
teichoic acid (WTA) and lipoteichoic acid (LTA) is D-alaninated at the C2 position of 
glycerol residue by the protein products of the dlt operon. This modification has been 
shown to affect bacterial autolysis and antimicrobial peptide sensitivity (14). In addition, 
the O-acteylation of the peptidoglycan at the C-6 hydroxyl group of the muramoyl 
residue inhibits the lytic action of muramidases such as lysozyme of the immune system 
and autolysins of the bacterial cell wall metabolic machinery (30) in a concentration 
dependent manner.  The main lipid constituents of bacterial cell wall, 
phosphatidylglycerol and diphosphatidylglycerol impart a net negative charge to the 
surface. Bacteria reduce the negative charge by incorporating positively charged 
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substitutions such as lysine on these phospholipids which enables the repulsion of 
antimicrobial cationic peptides (27). In Staphylococcus aureus, an intergral membrane 
protein MprF generates the lysyl-phophatidylglycerol which renders S.aureus resistant to 
antibiotics such as  gentamycin and vancomycin and antimicrobial peptides (25). It also 
protects S.aureus from neutrophil mediated killing and the mprF mutant was attenuated 
in a mouse model of sepsis and septic arthritis (28). Two paralogs of mprF (mprF1 & 
mprF2) were recently characterized in E. faecalis 12030 and it was shown that only 
mprF2 contributed to amino-phospholipid formation, antimicrobial peptide resistance and 
unlike in S.aureus mprF in E. faecalis did not play a role in virulence (2). The 
peptidoglycan hydrolyzing enzymes (autolysins) also play an important role in cell wall 
turnover and lysis. Three autolysins have been described in E. faecalis AtlA, AtlB and 
AtlC.  Septum digestion for cell division and cell wall separation are major functions of 
AtlA while AtlB can substitute for AtlA, although at a very low efficiency. No prominent 
function has been attributed to AtlC (24). The two extracellular proteases gelatinase and 
protease mediate cell lysis via proper cleaving and activation of AtlA.  Hence, both 
gelatinase and AtlA mutants are completely resistant to autolysis (36).  
We have previously shown that a sigma54 (rpoN) mutant in E. faecalis V583 is 
resistant to lysis. Mutation in the genes (oatA ,dlt, tag, pgdA, atlA ,gelE and sprE)  whose 
products play an important role in cell wall modifications, render the cell susceptible to 
lysis. Here we show that deletion of rpoN in the lysis susceptible mutant backgrounds 
protect the otherwise susceptible strains suggesting that RpoN regulates cell lysis in a 
manner that is independent of the known modifications. Thus, on the basis of data 
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presented in this study, we postulate the presence of a certain cell wall modification in E. 
faecalis V583 has not previously been already described. 
139 
 
 
4.2 Materials and Methods 
Bacterial Strains and Growth Conditions 
Enterococcus faecalis strains were cultured in Todd-Hewitt broth (THB) or 
Trypticase soy broth (TSB; BD Biosciences) unless otherwise stated. The media was 
supplemented with appropriate antibiotics whenever required. The bacterial strains used 
in this study are listed in Table 4-1. Escherichia coli electron blue from Strategene was 
used for propagation of plasmids and cultivated in Luria-Bertani (LB) broth 
supplemented with appropriate antibiotics whenever necessary. For E. faecalis 
chloramphenicol (Cm) and spectinomycin were used at a concentration of 15 µg/ml and 
500 µg/ml respectively whereas for E.coli chloramphenicol was used at 10 µg/ml while 
spectinomycin was used at 150 µg/ml. 
Construction of Isogeneic Deletion Mutants. 
Isogenic deletion of genes encoding proteins that play a role in enterococcal cell 
wall modification  was achieved using a previously published protocol with the E.coli-
enterococcal shuttle vector pLT06 (38). The primers and plasmids used in this study are 
listed in Table 4-2 and Table 4-3 respectively. For cloning purposes, the P1/P2 and P3/P4 
primer pairs were designed with EcorI/BamHI and BamHI/PstI restriction sites 
respectively. Using primer pair EF0783P1/P2 and EF0783P3/P4, the upstream and 
downstream regions of o-acetlytransferase gene (oatA) were PCR amplified. Post 
amplification, the products were digested using BamHI enzyme, religated to one another 
and amplified using EF0783P1/P4 to generate the insert fragment to delete oatA. The 
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amplified insert was digested with enzymes EcoRI/PstI and ligated with a similarly cut 
pLT06 deletion vector to generate pVI08. E10B was used to propagate the vector and it  
Table 4-1 E. faecalis strains used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Description Reference 
V583 Parental strain Clinical isolate 
VI01 V583 ΔrpoN (20) 
VI02 V583 ΔoatA This study 
MG07 V583 ΔmptR Chapter 3 
MG08 V583 ΔlpoR Chapter 3 
MG09 V583 ΔmpoR Chapter 3 
MG10 V583 ΔmphR Chapter 3 
VI09 V583 ΔrpoNΔoact This study 
VI10 V583 ΔrpoNΔdlt This study 
VI11 V583 ΔoatAΔdlt This study 
VI12 V583 ΔrpoNΔoatAΔdlt This study 
VT03 V583 ΔgelE ΔsprE (37) 
VI14 VT03 ΔrpoN This study 
VI21 VT03 pKS82; spec
r
 This study 
VI22 VI14 pKS82; spec
r
 This study 
VI29 VI01 pMV158GFP; tet
r
 This study 
VI30 VI14 pMV158GFP; tet
r
 This study 
VI37 VI01 pKS12(A); spec
r
 This study 
VI44 V583 ΔatlA This study 
VI45 VI01 ΔatlA This study 
VI48 V583 Δtag This study 
VI49 VI01 Δtag This study 
V150 V583 ΔpgdA This study 
VI51 VI01 ΔpgdA This study 
KS20 V583 Δdlt This study 
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Table 4-2 Oligonucleotides used in this study.  
 
Primers Sequence (5'-3') 
EF0783P1 GAGAGAATTCTTGATGCCTTAGTGAGTCGT 
EF0783P2 CTCTGGATCCCTTGCTATTTGCTGTCTGATT 
EF0783P3 GAGAGGATCCCAGTAGCAAGAAACTTCCAG 
EF0783P4 CTCTCTGCAGGCCAAACCAGCAGCAACAAT 
EF0783-Up GTTACAACAGCTAGATCCAGA 
EF0783-Down AGATCACTCGTACCAAACGTA 
DltP1 GAGAGAATTCTAAGTGGTATGTCTCGTTATG 
DltP2 CTCTGGATCCCATTATCATTCACCTCCTAAG 
DltP3 GAGAGGATCCTAGTTTCAGAAAGGATGGAATG 
DltP4 CTCTCTGCAGAGTCAATTTCATGTGTGGACA 
Dlt-Up CCTTCTCCAACTACCGCAAC 
Dlt-Down AATGTCGTACTGCCTGCATC 
TagP1 TGAAGAATTCAAAGGTACAGG 
TagP2 CTCTGGATCCCGGTCTCCATCTTAATACTGT 
TagP3 GAGAGGATCCCAGAAGTATCAACCACACAG 
TagP4 CTCTCTGCAGGCAGCATATGGATTTTGAATG 
Tag-Up GGAATAGATCCAGCTGCG 
Tag-Down CCTTCTAAACGAACTTCTGG 
PgdAP1 GAGAGAATTCGCTTGATTTGCTTGCAGTGC 
PgdAP2 CTCTGGATCCATGTCGCATACTTTCACTCCT 
PgdAP3 GAGAGGATCCTAGAGCAACTCGGAGCAC 
PgdAP4 CTCTCTGCAGGCCACCTTATGATCCAAGAG 
PgdA-Up GCGCTTGGCTACTGTTGTGC 
PgdA-Down TCGCTTGGCTACTGTTGTGC 
AtlAP1 GAGAGAATTCATCACCTCGTAAAACAGCA 
AtlAP2 CTCTGGATCCTGCTTTCCTTCTTTCGATACG 
AtlAP3 GAGAGGATCCAATGCAATACGGAATCAGCAT 
AtlAP4-SphI CTCTGCATGCATAACCGACACGTTCACTTT 
AtlA-Up TGGTATAAGGTCCTTTGCCT 
AtlA-Down GAACGTCCAATCCAATTTCG 
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Table 4-3 Plasmids used in this study. 
 
was then transformed into E. faecalis V583 cells. The temperature shift and generation of 
the mutant was achieved as previously described (38). The deletion was confirmed using 
EF0783-Up and EF0783-Down primers. Similarly, Δdlt, ΔtagA and ΔpgdA were 
generated in E. faecalis V583 as well as E. faecalis V583 ΔrpoN (VI01) (20) 
backgrounds. 
To generate the rpoN mutant  in a gelatinase and serine protease free background, 
the deletion vector construct pKS70 was transformed into a previous described protease 
mutant E. faecalis VT03 strain (37). 
Plasmid Description Reference 
pLT06  Parent Deletion vector; chloramphenicol resistance  (23) 
pVI01 rpoN deletion vector (20) 
pVI08 pLT06 containing engineered oatA deletion This study.  
pVI10 pLT06 containing engineered rpoN + oatA deletion  This study. 
pVI14 pLT06 containing engineered tagB deletion  This study. 
pVI15 pLT06 containing engineered  pgdA deletion  This study. 
pVI17 pLT06 containing engineered atlA deletion This study. 
pKS101 pLT06 containing engineered dlt deletion This study 
pMV158GFP Gram-positive replicative vector: GFP
+
 Tet
r 
 (1) 
pKS12 (A) Derivative of pTCV - LacSpec (Del Papa MF & 
Perego M (9)) devoid of erythromycin resistance 
cassette; Promoter less lacZ  Spec
r
 
 L.E. Hancock  
(This study) 
pKS82 pKS12 (A) derivative carrying the constitutive 
malM promoter from pMV158GFP; LacZ
+
 Spec
r
 
This study 
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Extracellular DNA Release Assay 
eDNA release was used  an indicator of lysis and measured using a double 
stranded DNA specific dye SYTOX® green as previously described (20). 
Fratricide Assay 
Co-culture assay  was performed as described earlier using VT02 (37) as the 
attacker VT03 (37) or VT03ΔrpoN as the target. 
For quantitative detection of lysis, the target strain harboring pKS12 (A) (low 
copy lacZ vector) and hence expressing LacZ was used. After 24 hrs of co-culture, lysis 
was determined by β-galactosidase assay. 
Statistical Analysis 
Statistical analysis of quantitative detection of eDNA release was performed using 
GraphPad Prism 4 software (San Diego, CA). Non-parametric t-test was used to assess 
the statistical significance between the mutants, the wild type parental strain E.faecalis 
V583 and the rpoN mutant VI01. 
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4.3 Results & Discussion 
The bacterial cell wall functions as a physical barrier and protects the cell from 
the lytic action of several bacterial enzymes as well as host defense molecules such a 
lysozymes. Lysozymes are muramidases produced by the innate immune system  cells 
and cleave at the beta 1-4 linkages between the N-acetylmuramic acid (NAM) and N-
actyl glucosamine (NAG) in the bacterial peptidoglycan causing the lysis of bacterial 
cells (19). Similarly the bacterial autolysins such as AtlA in enterococci (11) and 
staphylococci (5), LytA in pneumococci (33) and MurA in Listeria(7) are responsible for 
proper septation of these bacteria.  Like lysozyme, these autolysins also target the beta 1-
4 linkages of NAM and NAG, giving credence to their role in bacterial lysis.  The atlA 
mutant is resistant to autolysis. Sensing the susceptibility to such lytic agents, bacteria 
have evolved to be better prepared against their action and several modifications to the 
bacterial cell wall architecture are great examples of that adaption. The cell wall 
polymers associated with enterococcal cell wall are the type specific antigen on the outer 
surface responsible for the serospecificity of enterococci and include the lipoteichoic acid 
which is the Group D antigen, the wall teichoic acid, NAM and NAG (16). Enterococci 
have developed modifications in some of these polymers to protect the cells from lysis. 
The resistance of E. faecalis rpoN mutant to lysis led us to hypothesize that deletion of 
rpoN might have resulted in the increase in the expression of one of the several protective 
modifications to the enterococcal cell wall. O-acetylation of the peptidoglycan at the C6-
hydroxyl group  of the muramyl residue on NAM (12) and D-alanylation at the C2-
position of the glycerol residue in LTA and WTA (14) are known to protect against the 
lytic action of muramidases (3, 26, 29). Our data confirms their protective role in E. 
faecalis because deletion of the oatA gene and dlt operon resulted in an increase in eDNA 
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release (Figure 4-1). Also, O-acetylation and D-alanylation provide protection in a 
balanced manner because deletions of both oatA and dlt together had a cumulative effect 
on lysis as observed by greater eDNA release suggesting that one modification 
compensated for the absence of another and when both are absent the organism becomes 
more susceptible to lysis. Surprisingly, in the double mutants, ΔoatAΔrpoN and 
ΔdltΔrpoN and the triple mutant ΔoatAΔdltΔrpoN, the absence of RpoN provided 
protection from lysis and reverted the phenotype to mimic the ΔrpoN (Figure 4-1) 
 
Figure 4-1 Extracelleular DNA release Assay using mutants defective in cell wall 
modification 
Quantification of eDNA released in the culture supernatants of overnight grown cultures 
using SYTOX green DNA dye. V583 (parent strain); VI01 (V583 ΔrpoN); VI02 (V583 
ΔoatA); VI09 (V583 ΔrpoN ΔoatA); KS20 (V583 Δdlt); VI10 (V583 ΔrpoNΔdlt); VI11 
(V583 ΔoatAΔdlt); VI12 (V583 ΔrpoN ΔoatA Δdlt). *, significant p value less than 0.001 
in comparison to VI02; **, significant p value less than 0.001 in comparison to KS20; 
***, significant p values less than 0.001 in comparison to VI11. 
 
It has been previously shown that a fratricidal (sibling killing sibling) mechanism 
is responsible for eDNA release in E. faecalis (36). In a homogenous population of cells, 
certain heterogeneity arises when a small group of cells fail respond to quorum and this 
population is subject to killing by the larger population of cells that respond to the 
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quorum. This population becomes the source of eDNA to the rest of the population and 
aid in biofilm formation. The fratricidal mechanism is mediated by the two extracellular 
proteases gelatinase and serine protease and is a result of their activity on the autolysin 
AtlA. In the absence of these proteases the cells become increasingly susceptible to lysis 
when co-cultured with cells that produce both these enzymes (36). In order to assess the 
role of RpoN in fratricide and to determine whether the protection observed in the 
absence of RpoN is protease independent, we deleted rpoN in a previously described 
mutant lacking both the proteases and tested it as a target strain in the fratricide assay. 
Similar to eDNA release assay, deletion of rpoN in VT03 confered protection to the 
target strain and reduced death as measured by beta galactosidase activity (Figure 4-2). 
Thus, independent of the mode of lysis (autolysis or fratricicde) absence of rpoN 
conferred novel mechanism of protection to the susceptible cells.  
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Figure 4-2 Beta Galactosidase Assay for quantitative detection of fratricide using 
VT02 (ΔsprE) as the attacker strains.                   
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In addition, the charge on bacterial cell surface also plays an important role in 
maintaining the integrity of cells when faced by unfavorable osmotic conditions. The 
polymers on bacterial cell wall make them sturdy and help withstand harsh environmental 
conditions and provide protection from the action of antimicrobial cationic peptides.  
By mutational analysis and NMR spectroscopy, the tag operon has been proposed 
to be responsible for the cell wall rhamnopolysaccharide synthesis in E. faecalis. It also 
mediates evasion from the complement system (15). In S.aureus, the reduction in proton 
gradient across the bacterial membrane in a tag negative mutant was  shown to regulate 
the action of autolysin by modulating the pH because AtlA exhibits lower activity in 
acidic pH (4). In this study, we deleted the entire tag operon in E. faecalis and assessed 
its role in lysis and eDNA release. In contrast to the Staphylococcus study, E. faecalis tag 
mutant was not susceptible to lysis and had no effect on eDNA release (Figure 4-3).  
          
No statistical significance observed between V583 and VI48 as well as VI01 and VI49. 
 
Figure 4-3 Quantitative detection of eDNA release using SYTOX Green DNA 
staining dye. V583, parent strain; VI01, ΔrpoN; VI48, Δtag; VI49 ΔrpoN Δtag. 
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Interestingly, in the conditions tested by us, the tag mutant was defective is 
capsule biosynthesis. The higher molecular weight band in the capsule gels (130 kDa) 
was absent in the tag mutant and rpoN deletion did not revert that phenotype suggesting 
that RpoN has no role in capsule synthesis (Figure 4-4). To the best of our knowledge, 
this is the first report where we describe the presence of a second capsule biosynthesis 
operon in addition to the cps operon in E. faecalis V583. Blastp analysis of tag operon 
from E. faecalis V583 with the other sequenced strains of enterococci revealed that all 
the strains that harbor the capsule operon also contain the tag operon suggesting the 
requirement of both operons for capsule synthesis. These two operons do not appear to be 
transcriptional linked because they are located far apart on the chromosome. Our future 
studies will entail the understanding of tag operon regulation and its functional 
characterization in E. faecalis V583. 
                         
Lane A, V583; Lane B, VI01 (ΔrpoN); Lane C, VI40 (rpoN complement); Lane D, VI48 
(Δtag); Lane E, VI49 (ΔrpoNΔtag) 
 
In addition to O-acetylation and D-alanylation, deacetylation of NAG residues by 
peptidoglycan N-acetyl glucosamine deacetylase (pgdA) has also been proposed. 
Figure 4-4 Detection of cell wall polymers on 10% polyacrylamide gels stained  
using cationic dye, Stains All. 
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However, in E. faecalis JH2-2, no obvious changes to cell wall composition were 
observed in a pgdA mutant (17). Similarly, in our study, the pgdA mutant phenocopied 
the parental strain in eDNA release and lysis and deleting pgdA in VI01 background 
resulted in phenotype similar to VI01 (data not shown) ruling out the possibility of this 
modification being involved in RpoN mediated resistance.  In E. faecalis V583, RpoN 
regulates the expression of four sugar uptake systems namely Mpt, Mpo, Mph and Lpo 
with the help of specific activator proteins that are located upstream of the respective 
sugar uptake systems (18). Of the four sugar uptake systems, mpt operon is the major 
glucose/mannose uptake system in most firmicutes including enterococci (41). We have 
previously shown in Chapter 3 that the mutant lacking the mannose PTS system activator 
protein MptR, phenocopies the growth pattern of rpoN mutant in CDM medium with 10 
mM glucose. The absence of all the known cell wall modifiers in an rpoN mutant did not 
alter its lysis resistance (Figure 4-1). This led us to hypothesize that RpoN could regulate 
lysis via the PTS systems whose expression is controlled by RpoN.  Inorder to test this 
hypothesis we assessed the role of the aforementioned activator mutants of the PTS 
system in eDNA release. Similar to the phenotype observed in growth pattern, of the four 
PTS system specific activator protein mutants, only mptR mutant phenocopied the rpoN 
mutant. Extracellular DNA release was significantly decreased in the ΔmptR, as observed 
by Sytox Green staining (Figure 4-5). 
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Figure 4-5 Quantitative detection of extracellular DNA in activators mutants using 
SYTOX Green. 
VI01, ΔrpoN; MG07, ΔmptR; MG08,ΔlpoR; MG09,ΔmpoR; MG10,ΔmphR. 
*, significant p value less than 0.001 in comparison to V583; §, significant p value leass 
than 0.001 in comparision to VI01 and MG07. 
 
The mpt operon consists of four genes namely mptB, mptA , mptC and mptD that 
encode of cytosolic proteins EIIB & EIIA and transmembrane proteins EIIC and EIID 
respectively. Certain bacteria produce small antimicrobial peptides called the bacteriocins 
that target other closely related bacteria and/or a broader spectrum of bacteria including 
pathogens. Pediocins like bacteriocins or Class IIa bacteriocins are of 38-47 amino acid 
long peptides that display a broad spectrum of activity against several organisms 
including Listeria and Enterococcus (13).  It has been well established that the Class IIa 
bacteriocins use the mannose PTS system (mpt) as a cellular receptor to lyse susceptible 
organisms (8) (10, 18). It has been previously shown that the cytosolic EIIAB complex is 
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not involved in conferring the sensitivity to these bacteriocins (10). There have been 
conflicting reports regarding the involvement of MptC and/or MptD as receptors to the 
Class IIa bacteriocins (8, 10, 31). However, it is clear that MptC and MptD, the two 
transmembrane proteins of the mpt pathway have a role in determining the sensitivity of 
the bacteria to Class IIa bacteriocin and the lactococcal bacteriocin lactococcin A (a Class 
IIc bacteriocin). The extracellular loop in MptC has been shown to interact with class IIa 
bacteriocins and a complex interaction occurs between the lactococcinA and regions in 
IIC and IID (22). Interestingly, development of spontaneous resistance to bacteriocins has 
been described and one mechanism of resistance is the down regulation of the mannose 
PTS system (21). These observations and our results that an mptR mutant mimics the 
resistant phenotype of the rpoN mutant led us to the hypothesis that the MptC/MptD 
receptor complex may play an important role in susceptibility of enterococci to autolysis 
during normal growth conditions as a part of a global regulatory mechanism of controlled 
lysis. The ongoing studies in our laboratory are focused on understanding the regulation 
of lysis resistance mediated by RpoN via MptC/MptD.  
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Directions. 
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Enterococci have emerged as third leading causative agents of hospital acquired 
infections (19). Antibiotic resistance and acquisition of several virulence traits have 
contributed to its emergence as a pathogen. Development of resistance to the drug of last 
resort, vancomycin (8, 16, 20) and to the newer antibiotics such as linezolid (3, 50), 
daptomycin (23, 28, 34) and dalfopristin (17) have made enterococcal infections difficult 
to treat. In addition to acquiring antibiotic resistance, a number of virulence factors 
associated with enterococci such as capsule, aggregation substance, cytolysins, 
extracellular proteases, pili, biofilm enhancing factors etc. play an important role in the 
progression of a benevolent microorganism to a pathogen (4, 5, 13, 22, 25, 29, 35, 41, 43, 
47-49). Enterococci are sensitive to class IIa bacteriocins or pediocin like bacteriocins 
produced by lactic acid bacteria (10). The sensitivity to class IIa bacteriocins is due to the 
mannose/glucose sugar uptake system or Mpt system in enterococci because Mpt system 
functions as a receptor for these bacteriocins (7). In enterococci and other bacteria such 
as Listeria, the mpt operon is regulated by the alternate sigma factor RpoN (6, 15).  
In this study we tried to understand the role of RpoN in enterococcal biology 
beyond its known role in sensitivity to class IIa bacteriocins. RpoN is an alternate sigma 
factor that recognizes the signature -12/-24 sequence upstream the genes it regulates (27). 
It requires the binding of a transcriptional activator located upstream from the RpoN 
signature consensus for open complex formation and transcription initiation. These 
transcription activators possess both ATPase activity that provides the required energy 
and helicase activity that cause the bending of DNA (42). Four such activators have been 
identified upstream of the four sugar uptake systems (mpt, mpo, lpo, mph) regulated by 
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RpoN (15). Biofilm is a characteristic of infective endocarditis, urinary tract infections 
and surgical site infections caused by enterococci. Planktonic or sessile bacteria adhere to 
an available surface such as damaged heart valves, urinary tracts, catheters etc. and form 
microcolonies that are held together by matrix components secreted by the bacteria and 
contributed by the host immune systems such as fibrins and platelets (33). In enterococci, 
two extracellular proteases, gelatinase and serine proteases play an important role in 
regulating cell lysis (49). Gelatinase is pro-lytic in nature and causes lysis of cells while 
serine protease is anti-lytic in nature and protects the cells from lysis (45). Both these 
proteases are co-regulated and under the control of the fsr, the quorum sensing operon 
(39). The killing of a by-stander population that do not respond to quorum is called the 
‘bystander effect’ and contributes one of the main matrix component i.e. extracellualar 
DNA that binds the biofilms (44). Autolysis and fratricide contribute to eDNA release. 
Apart from GelE and SprE mediated release of eDNA, no other regulation of eDNA 
release has been described. Our results described in Chapter 2 provide supporting 
information about the involvement to the alternate sigma factor RpoN in eDNA release. 
The rpoN mutant was resistant to lysis and no eDNA was detected in the culture 
supernatant of the rpoN mutant. The findings reported in Chapter 4 describe the 
dominance of the lysis resistant phenotype of ΔrpoN even in the presence of mutations 
that make enterococci susceptible to lysis. In Chapter 3 and Chapter 4, we further explore 
the potential involvement of sugar uptake systems in modulating lysis.  In other bacteria, 
proteins and polysaccharides have been shown to be important matrix components (2, 12, 
26) but little is known about other matrix components in enterococcal biofilms. In 
Chapter 2 we provide evidence for the presence of proteins in enterococcal biofilms at 
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later stages in biofilm accumulation. Proteinase K treatment of ΔrpoN biofilms affected 
accumulation of biofilms at early time points whereas in the parental strain, the treatment 
perturbed biofilms only at later stages. This led us to the conclusion that proteins play a 
role in later stages of enterococcal biofilm development. However, it does not rule out the 
possibility that in the parental strain, proteins in biofilm are masked by other unknown 
components that may be absent in ΔrpoN biofilms. Thus in Chapter 2, we substantiate the 
presence of protein in enterococcal biofilms and describe the role of RpoN in regulating 
eDNA release by affecting autolysis in a protease independent manner. The finding in 
Chapter 2 has been published in Journal of Bacteriology (21). 
RpoN regulates diverse functions in several bacteria. For example in E.coli, 
V.cholerae P.aeruginosa and V.fischeri, RpoN controls flagellar biosynthesis (37, 38, 46, 
51, 53). In L.monocytogenes, RpoN is responsible for mesentericin sensitivity 
osmotolerance and regulates several carbohydrate metabolism related genes (1, 6, 30). 
RpoN is required for the survival of B.cenocepacia within macrophages (40) and in 
Borrelia burgdorferi RpoN is required to maintain the tick-mammalian enzootic life 
cycle (32) 
However, the knowledge about its role in E. faecalis V583 is restricted to 
bacteriocin sensitivity and regulation of sugar uptake PTS systems. In order to gain 
insight into the nature of genes regulated by RpoN in E. faecalis, we generated a 
transcriptional profile of ΔrpoN in comparison to the parental strain and the 
complemented strain using microarray analysis. In Chapter 3, the finding of this study 
has been described. Almost 10% of the genome is differentially regulated by RpoN and 
that includes a number of genes encoding transport and binding proteins, proteins related 
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to metabolic function and several other transcription regulators. Since, RpoN regulates 
the function of Mpt system; there was an extensive overlap of differentially expressed 
genes between the transcriptional profile of ΔrpoN and that of the previously described 
mpt mutants (31). Our data indicate a role for RpoN in carbon catabolite repression or 
CCR in enterococci because several genes with catabolite responsive elements (cre) in 
their promoter regions were differentially regulated in ΔrpoN. 
In Chapter 3, using a rabbit model of infective endocarditis and mouse model for 
catheter associated urinary tract infections (CAUTI), we assessed the role of RpoN in 
enterococcal virulence. The bacterial burden in the organs of rabbits and mice infected 
with ΔrpoN was significantly lower in comparison to the wild type. The rpoN mutant 
grew poorly in chemically defined medium with glucose at 10mM and 50mM 
concentration. At physiologically relevant glucose concentrations i.e. 5 mM (18, 52) 
ΔrpoN was not able to reach a cell density similar to the wild type. This defect justifies 
the inability of ΔrpoN to establish an infection in the rabbit endocarditis and CAUTI 
studies. Our data in chapter 3 describes the indispensability of RpoN for growth of 
enterococci in nutrient limiting conditions and to establish infection. It also highlights the 
regulatory effect of RpoN on genes in addition to the sugar PTS systems.  
Presence of capsular polysaccharide (47) and modification on the cell wall 
polymers of enterococci such as O-acetylation (9, 36), D-alanylation (11) and 
deactylation (14) that have a protective function have been described. The findings in 
Chapter 4 show that the lysis resistant phenotype of RpoN is independent of any of the 
known modifications. In Chapter 4, a new mechanism of resistance to lysis involving the 
mannose PTS system components, MptC and MptD has been proposed. It is based on the 
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knowledge that these two transmembrane proteins of mpt operon play an important role 
in bacteriocin mediated sensitivity to lysis (7). Using a series of permutations and 
combinations of MptC and D protein fusions, it has been shown that these proteins acts as 
receptors for docking bacteriocins and thus regulate sensitivity (24). There exists as 
possibility that these transmembrane proteins could bind to unidentified bacteriocins in E. 
faecalis genome that modulate lysis. In order to test this hypothesis, experiments 
involving expression of mptCD under the control of a constitutive or inducible promoter 
independent of mptBA in ΔrpoN is underway. The rationale underlying this approach is 
that expression of mptCD in ΔrpoN may revert the lysis resistant phenotype of ΔrpoN.   
Another project of interest stems from the identification of a second pathway 
involved in capsule biosynthesis. During the course of our research we found that 
presence of teichoic acid biosynthesis genes (EF1172-EF1175) was essential for capsule 
synthesis. Both capsule operon (cps) and teichoic acid biosynthesis genes (tag) are 
required for capsule biosynthesis because no capsule is observed when cell wall 
preparations were analyzed on polyacrylamide gels stained using the Stains-All dye in the 
absence of either one of the operon. Interestingly, the cps and tag operon are located at a 
distance on the chromosome and do not appear to be transcriptionally linked. Given these 
exciting preliminary finding, the role of tag operon should be further tested to understand 
its contribution to enterococcal capsule biosynthesis. 
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